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 It is well established that hypertension decreases endothelium-dependent vasomotor 
function, partially by excessive generation and reduced scavenging of reactive oxygen species 
(ROS).  Nevertheless, at appropriate levels, some ROS can act as signaling molecules in the 
vasculature and contribute to endothelium-dependent dilation. Recent evidence in healthy 
resistance arteries suggests that the ROS species hydrogen peroxide (H2O2) acts as an 
endogenous endothelium-dependent dilator through a non-nitric oxide, non-prostaglandin 
(3NP) pathway. The aim of this study was to investigate the role of endogenous H2O2 in 3NP-
mediated endothelium-dependent dilation of rat mesenteric arteries, and the changes that 
occur in these vessels with essential hypertension. 18-20wk old male spontaneously 
hypertensive rats (SHR; n=24) had an elevated systolic blood pressure of 198±6mmHg 
compared to 93±4mmHg (p<0.001) in the age matched normotensive Wistar-Kyoto rat 
(WKY; n=22). Isolated mesenteric arteries were preconstricted with norepinephrine (NEPI), 
followed by exposure to increasing doses of the endothelium-dependent dilator acetylcholine 
(ACh), which revealed vasomotor dysfunction in the SHR (maximal dilation: WKY: 
94.8±1.3% vs. SHR: 75.2±2.9%, p<0.001). Incubation of the vessels with the non-specific 
cyclooxygenase (COX) inhibitor indomethacin (INDO) restored the ACh response in the SHR 
to the level of the WKY control (area under the curve: WKY: 354.6±8.6 vs. SHR INDO: 
350.2±12.2, p>0.05) indicating that the release of constrictory prostaglandins from COX 
contribute to endothelial vasomotor dysfunction. Co-incubation of vessels with INDO and the 
nitric oxide synthase inhibitor N -nitro-L-arginine (LN) inhibited dilation in SHR 
(46.2±4.8%, p<0.001) but not in WKY (98.3±1.5%, p>0.05), indicating an elevated 3NP 
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component in WKY over SHR. Further co-incubation with the H2O2 scavenger catalase 
(CAT), LN, and INDO inhibited the 3NP component to a greater extent in SHR (29.7±3.1%, 
p=0.062) than in WKY (91.6±2.5%, p<0.05). The responses of SHR and WKY mesenteric 
arteries to the endothelium-independent dilator sodium nitroprusside, the receptor-mediated 
constrictor NEPI, and the electrochemical constrictor KCl were no different between LN 
INDO and CAT LN INDO conditions. These data suggest that endogenous H2O2 has a greater 
role in mediating endothelium-dependent dilation in the mesenteric resistance arteries of 
SHR. Interestingly, in SHR, co-incubation with LN INDO improved dilation over LN alone 
(46.2±4.8% vs 23.3±3.2±, p=0.001), and CAT LN INDO decreased dilation from LN INDO 
to a similar extent, suggesting that COX-inhibition could be a source of H2O2 for endogenous 
vasodilation. Western blotting revealed a 54% increase in COX-1 protein expression in the 
SHR mesenteric arteries (WKY: 1.00±0.18 (n=9) vs. SHR: 1.54±0.17 (n=13), p<0.05), but no 
difference in the expression of the pro-oxidant enzyme p47phox, and the anti-oxidant 
enzymes CAT, SOD-1, and SOD-2. Administration of exogenous H2O2 to NEPI 
preconstricted mesenteric arteries revealed a dose-dependent dilation that was no different 
between SHR and WKY, and incubation of isolated WKY and SHR mesenteric arteries with 
CAT reduced the accumulation of H2O2 to a similar extent, as assessed by the H2O2-specific 
fluorescent dye Amplex Red. In conclusion, endogenous H2O2 is a vasodilator in the 
mesenteric arteries of SHR and WKY rats in the absence of nitric oxide and prostaglandins. In 
the SHR, COX-1 inhibition may allow endogenous H2O2 to become bioavailable for 
vasodilation. This study is the first to show a role for endogenous H2O2 in maintaining 
endothelium-dependent dilation in hypertensive rat resistance arteries, and provides evidence 
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The study of vascular function has progressed immensely since Furchgott and Zawadski 
(1980) first noted the importance of the vascular endothelium in the maintenance and control 
of vascular tone. Since this seminal work, three major pathways responsible for endothelium-
dependent dilation have been identified, as has a relationship between endothelial dysfunction 
and the development of cardiovascular disease (Feletou and Vanhoutte, 2006). Nevertheless, 
many questions, both basic and applied, remain unanswered due to the complex interaction of 
the multiple and redundant mechanisms controlling vascular function and blood flow 
(Laughlin and Korzick, 2001). Among these mechanisms, a role for reactive oxygen species 
(ROS) is apparent, where pathological levels of ROS may cause impaired cell function 
whereas physiological levels of ROS act as signaling molecules necessary for normal cell 
function (Stone and Yang, 2006). Recent evidence suggests that the ROS species hydrogen 
peroxide (H2O2) may partially mediate the component of endothelium-dependent dilation 
remaining when nitric oxide (NO) and prostaglandin (PG) production are inhibited (Fujiki et 
al, 2005; Lacza et al, 2002; Matoba et al, 2000; Matoba et al, 2002; Matoba et al, 2003; Yada 
et al, 2003). This is termed non-prostaglandin, non-nitric oxide (3NP)-mediated dilation. 
However, the mechanisms responsible for the action of H2O2 as a vascular signaling 





ROS IN THE VASCULATURE.  
A) ROS Species 
Several species of ROS are present in the vasculature, including the short-lived superoxide 
anion (O2
-
) and hydroxyl radical (OH
-
), the more stable hydrogen peroxide (H2O2), and the 
reactive nitrogen species nitric oxide anion (NO) and peroxynitrite (ONOO
-
) (Paravicini and 
Touyz, 2006; and Droge et al, 2002) (Figure 1). The major producer of endogenous ROS in 
the vasculature is the NAPD(P)H oxidase enzyme, which is comprised of both membrane 
bound and cytosolic subunits (Rush and Aultman, 2007), but ROS are also produced by the 
mitochondrial respiratory chain, xanthine oxidase, cyclooxygenase (COX), cytochrome P450, 
and uncoupled endothelial nitric oxide synthase (eNOS) (Fulton et al, 1997; Feletou and 
Vanhoutte, 2006; Paravicini and Touyz, 2006). O2
-
 is the major ROS produced by these 
sources and can then be spontaneously or enzymatically dismutated to H2O2 or react with NO 
to produce ONOO
-
 (Feletou and Vanhoutte, 2006). H2O2, in turn, can be further dismutated to 
water and molecular oxygen by catalase (CAT), and by peroxidases such as the thiolate-
dependent glutathione peroxidase (GPx) (Stone and Yang, 2006). H2O2 can also be 
spontaneously converted to the highly reactive OH
-
 in the presence of metal cations via the 
Fenton and Haber-Weiss reactions (Feletou and Vanhoutte, 2006). Thus, the enzymatic 
conversion of H2O2 to H2O provides an antioxidant defense mechanism eliminating the 
oxidative stress and cellular damage caused by the non-enzymatic conversion of H2O2 to OH
-
. 
Interestingly, GPx appears to be a more effective antioxidant than CAT in endothelial cells 
since blockade of glutathione reductase, an enzyme necessary for the function of the 
glutathione redox cycle, greatly increased H2O2-induced cytotoxicity compared to no effect 
when CAT was inhibited (Suttorp et al, 1986). Nevertheless, addition of exogenous CAT 
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almost completely prevents endothelial cell damage that normally occurs in response to H2O2 
exposure, suggesting that the additional CAT provides an extracellular “sink” for the H2O2 
(Suttorp et al, 1986). In a complex interaction between many endogenous enzymes 
responsible for the production and scavenging of ROS, the level of cellular ROS is carefully 
regulated in vascular tissue, thereby controlling downstream signaling cascades in physiologic 
and pathologic scenarios.  
 
B) ROS as Signaling Molecules 
Although ROS are typically associated with damage, oxidative stress may also play an 
important role in vascular signaling. The most well known example of ROS signaling in the 
vasculature is the role of NO as an endothelium-derived relaxing factor causing dilation of the 
vascular smooth muscle (Palmer et al, 1987; Ignarro et al, 1987). Recent evidence supports 
the role of other ROS as signaling molecules. ONOO
-
, is typically associated with 
nitrosylation and impairment of both vascular and renal tissue (Chu et al, 2003), but is also a 
dilator of cerebral vessels through an ATP-sensitive potassium channel (KATP) mechanism 
(Wei et al, 1996). Similarly, O2
-
 produced by xanthine oxidase causes dilation of cerebral 
vessels that is partially dependent upon calcium-activated potassium channels (KCa) (Wei et 
al, 1996). H2O2 is required for the formation of PG by COX, since the presence of GPx causes 
a dose-dependent suppression of COX activity (Marshall et al, 1987). When compared to O2
-
 
and H2O2, the highly reactive OH
-
 is not likely to have a major role as a signaling molecule 
beyond its site of production (Paravicini and Touyz, 2006). In general, ROS species are 
involved in vascular signaling; however, the contribution of each species to overall vascular 
function remains undefined. 
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C) ROS and Gene Expression 
ROS may also play an important role in the modulation of gene expression in vascular cell 
types in a manner that has consequences in blood vessel function. For instance, Drummond 
and colleagues (2000) elegantly demonstrated that H2O2 causes a dose-dependent increase in 
eNOS mRNA and protein expression leading to increased NO production in bovine aortic 
endothelial cells. Similarly, Lauer et al (2005) demonstrated a 1.5-fold increase in eNOS 
protein content in the aorta of endurance trained wild-type mice with no training-induced 
change noted in transgenic mice over-expressing human endothelial CAT. This suggests that 
H2O2 was necessary for the exercise-induced up-regulation of eNOS. Finally, transgenic mice 
over-expressing the p22phox subunit of the NAD(P)H oxidase enzyme in vascular smooth 
muscle cells have a greater extracellular O2
-
 (Laude et al, 2005). As a compensation for 
greater O2
-
, these mice also over-expressed the extracellular isoform of SOD (ecSOD), 
leading to a greater dismutation of O2
-
 to H2O2 that can readily diffuse into the endothelium 
(Laude et al, 2005). As a consequence of increased intracellular H2O2, eNOS expression is 
increased leading to greater NO production. Over-expression of CAT inhibits the up-
regulation of eNOS, confirming the role of H2O2 as a stimulator of transcription for eNOS 
(Laude et al, 2005). Taken together, these studies imply that H2O2 may affect NO-mediated 






THE ROLE OF H2O2 AS A DILATOR IN THE VASCULATURE. 
A) General actions of H2O2 as a dilator 
Several studies have illustrated the complex role of exogenous H2O2 as a vasoactive 
chemical. Gil-Longo and Gonzalez-Vazquez (2005) uncovered four separate responses to 
exogenous H2O2 administered to WKY rat aortic rings. At low concentrations, H2O2 causes 1) 
an initial COX-dependent constriction followed by 2) an endothelium-dependent dilation 
related to K
+
 channel activation and NO release, and 3) an endothelium-independent dilation 
related to K
+
 channel activation at the smooth muscle layer. Furthermore, at concentrations of 
H2O2 greater than 100μmol/L there was 4) an irreversible dilation caused by vessel damage. 
Similar responses have been shown in the rat mesenteric vessels, where H2O2 dose-response 
curves result in a constriction at low concentrations and a phasic constriction followed by an 
endothelium-independent dilation at concentrations of H2O2 greater than 300μmol/L (Gao et 
al, 2003). This effect of exogenous H2O2 as an endothelium-independent dilator is not altered 
by mannitol, an inhibitor of OH
-
 destruction, or by stimulation of OH
-
 production through the 
Haber-Weiss and Fenton reactions, suggesting that OH
-
 is not responsible for the dilatory 
effects of H2O2 (Beny and von der Weid, 1991). Since exogenous H2O2 stimulates a complex 
interaction of mechanisms and may cause cellular damage, endogenous levels of H2O2 must 
be tightly regulated by robust antioxidant mechanisms to achieve the desired effect as a 
signaling molecule in the vasculature. 
 
B) H2O2 as an Activator of the COX Pathway and Hyperpolarization 
Few studies describe the precise mechanism by which H2O2 causes dilation in the 
mesenteric vasculature; however, a proposed mechanism is summarized in Figure 1. Hattori et 
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al (2003) administered exogenous H2O2 to denuded rabbit mesenteric vessels and measured 
changes in membrane potential. Through the extensive use of pathway inhibitors, it was 
shown that H2O2 activates COX to produce prostaglandin E2 (PGE2) and prostacyclin (PGI2) 
leading to the opening of sarcolemmal KATP-channels causing vascular smooth muscle 
hyperpolarization. The authors also demonstrated the involvement of the 5-lipoxygenase (5-
LO) pathway; however, they were unable to identify the downstream leukotrienes responsible 
for hyperpolarization. Unfortunately, the importance of this finding in terms of 3NP-mediated 
dilation is uncertain since the CAT inhibition of dilation occurs in the presence of the COX 
inhibitor INDO (Matoba et al, 2000), suggesting that PGs are not the main dilatory 
substances, although 5-LO derivatives may still be involved. Interestingly, H2O2 seems to 
have a differential effect on vascular function through a common K
+
-channel pathway. In a 
study by Lucchesi et al (2005), low concentrations of H2O2 (1-50μmol/L) caused 
endothelium-dependent dilation in phenylephrine (PE)- and pressure-contracted mouse 
mesenteric arteries. However, >50μmol/L H2O2 caused endothelium-independent constriction 
in KCl pre-constricted vessels, and this response was eliminated by the p38 MAP-kinase 
inhibitor SB203850 (Lucchesi et al, 2005). In addition, both dilation and constriction to H2O2 
were completely eliminated by the Ca
2+
-channel inhibitor nimodipine, while the addition of 
the KCa-channel inhibitors iberiotoxin and apamin did not alter dilation or constriction to 
exogenous H2O2. Since KCl preconstriction and Ca
2+
-channel inhibition eliminated dilation to 
exogenous H2O2, it suggests that H2O2 operates through hyperpolarizing the vascular smooth 
muscle, possibly by opening K
+
-channels separate from KCa-channels. Thus, it can be 
speculated that through an unknown K
+
-channel, H2O2 may cause the hyperpolarization of the 
cell membrane, closing voltage-gated Ca
2+
-channels (VGCC) in a manner similar to EDHF 
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 (McGuire et al, 2001) and inhibiting Ca
2+
-calmodulin-dependent 
myosin light chain kinase (CaCM-MLCK), reducing cross-bridge formation and causing 
relaxation (Guyton and Hall, 2000). However, this theory has not been thoroughly tested. In 
the mesenteric vasculature, mechanisms involved in the dilatory vasomotor effects of H2O2 
include metabolites of COX and 5-LO that cause hyperpolarization of the vascular smooth  
muscle (VSM) by K
+
 channel activation. 
 
C) H2O2 as a Dilator Through NO or Second Messenger Pathways 
H2O2 may be an endothelium-dependent dilator operating through mechanisms 
common to the NO pathway, although this theory remains controversial (Figure 1). In a study 
by Itoh et al (2003), SOD improved endothelium-dependent dilation of rabbit mesenteric 
arteries to ACh, an effect that was eliminated by the further addition of CAT or L-N
G
-
nitroarginine (L-NOARG). Furthermore, the endothelium-independent dilation to an NO 
donor was improved with SOD and inhibited with CAT while exogenous H2O2 increased 
cGMP induced vasodilation (Itoh et al, 2003). These findings support the theory that H2O2 
causes dilation through cellular mechanisms common to the NO pathway. Leung et al (2006) 
provided additional support for this theory as CAT caused a rightward shift in endothelium-
dependent dilation of rat femoral arteries to ACh, an effect that was eliminated with N -nitro-
L-arginine (L-NAME, abbreviated LN) or the sGC inhibitor ODQ. Incubation with either 
CAT or LN eliminated ACh-induced H2O2 accumulation in the endothelium of rat femoral 
arteries, and CAT reduced dilation in the presence of the “EDHF blockers” charybdotoxin 
plus apamin (Leung et al, 2006). This study suggests that H2O2 may be released by eNOS and 
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act through sGC to cause dilation at the vascular smooth muscle. However, H2O2 
administration has also been shown not to alter NO-induced dilation. The inhibition of 
endogenous CAT through the incubation of rabbit aortic rings with aminotraizole (AT) does 
not alter dilation to ACh, the calcium ionophore A23187, or the NO donor nitroprusside 
(Mügge et al, 1991). Thus, H2O2 may act as a dilator through stimulating the effectors of the 
NO pathway, although this theory remains controversial. 
H2O2 may also cause the release of a separate substance from the endothelium to cause 
dilation at the smooth muscle layer. Miura et al (2003) used cannulated coronary arterioles 
from patients undergoing cardiopulmonary bypass surgery and demonstrated that CAT alone 
inhibited 2/3 of the flow-mediated dilation and, along with LN, completely abolished flow-
induced H2O2 production in intact vessels. CAT did not alter endothelium-independent 
dilation to papaverine, and flow caused the accumulation of H2O2 only in the endothelium of 
intact vessels, and not in the smooth muscle layer. These findings suggest that H2O2 may 
activate a second messenger to cause dilation at the VSM. In a second human study, intestinal 
submucosal arterioles were excised from patients who did not have cardiovascular disease but 
were undergoing bowel operations (Hatoum et al, 2005). CAT completely inhibited the 3NP 
component of ACh-induced dilation; however, exogenous H2O2 caused dilation in 
endothelium-intact vessels, and constriction in denuded vessels (Hatoum et al, 2005). Since 
the exogenous H2O2 did not cause direct dilation of the smooth muscle, these results suggest 
that endogenous H2O2 produced in the endothelium stimulates the release of a substance 




ENDOGENOUS H2O2 IN NON-NO, NON-PG (3NP)-MEDIATED DILATION. 
A) Evidence Supporting H2O2 Involvement in 3NP-mediated Dilation 
Recent evidence suggests that H2O2 may be involved in 3NP-mediated dilation, the 
component of dilation that remains following NO and PG blockade. This reveals an important 
link between oxidative stress and vascular function (Figure 1). Careful work by Matoba et al 
(2000), where the effectiveness of the NO and PG blockade was ensured with additional 
downstream blockers, demonstrated that the addition of CAT eliminated stimulated 
endothelial H2O2 production, 60% of the endothelium-dependent dilation, and greatly reduced 
hyperpolarization to ACh in mouse mesenteric arteries. The inhibited endothelium-dependent 
dilation to CAT was reversed following incubation with AT, and hyperpolarization in 
response to an endothelium-independent agonist (levcromakalim) was not altered by CAT 
(Matoba et al, 2000). Interestingly, when the vessels of control mice were incubated with only 
CAT and INDO, dilation was not altered from control levels in wild-type mice, but was 
greatly inhibited in eNOS
-/-
 mice (Matoba et al, 2000). This suggests that H2O2 acts as an 
endothelium-dependent dilator only in the absence of NO. In 2003, Matoba et al (2003) 
identified H2O2 as a 3NP-mediated dilator in pig coronary vessels through the inhibitory 
actions of CAT on BKY induced dilation, hyperpolarization, and H2O2 production identified 
by electron spin resonance detection. Similarly, Yada et al (2003) measured significant 
inhibition of ACh-induced dilation in the presence of N
G
-monomethyl-L-argninine (L-
NMMA), the non-selective COX inhibitor ibuprophen, and CAT in the small coronary 
arteries (>100μm) and arterioles (<100μm) of dogs. A further study by Morikawa et al (2003) 
provides possibly the most convincing evidence that H2O2 is involved in 3NP-mediated 
dilation by using the Cu,Zn-SOD knockout  (SOD-1
-/-
) mouse model. In the presence of CAT, 
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the 3NP component of ACh-induced dilation is reduced from 75% to 25% in the mesentery of 
control mice with a corresponding 50% reduction in hyperpolarization. Conversely, SOD-1
-/-
 
mice demonstrate no H2O2 release with ACh stimulation and no effect of CAT on ACh-
induced dilation or hyperpolarization (Morikawa et al, 2003). This finding supports the 
involvement of H2O2 in 3NP-mediated dilation since the knockout mice would not produce 
H2O2 endogenously, thus it would not be available for dilation. In the SOD-1
-/-
 mice, the SOD 
mimetic TEMPOL that scavenges O2
-
 and produces H2O2 (Chen et al, 2007; Fulton et al, 
1997), improved ACh-induced dilation, an effect which was reversed by the further addition 
of CAT (Morikawa et al, 2003). Conversely, the incubation of wild-type mesenteric vessels 
with TEMPOL did not alter ACh-induced dilation; however, co-incubation with TEMPOL 
and CAT caused a reduction in dilation, suggesting that the CAT effect on H2O2 was 
preserved. These findings suggest that when adequate endogenous O2
-
 scavengers exist, the 
endogenous H2O2 is involved in 3NP-mediated dilation; however, when the level of SOD is 
reduced, TEMPOL improves dilation by providing additional H2O2 to act as a dilator. In this 
context, SOD-1 may act as a major producer of H2O2 for dilation. 
 
B) Evidence Against H2O2 Involvement in 3NP-mediated Dilation 
In light of the evidence suggesting that H2O2 is involved in 3NP-mediated dilation, 
Ellis et al (2003) undertook a thorough study of the role of this ROS in the mouse mesenteric 
arteries.  In wild type or type-II diabetic mice (db/db), CAT did not alter endothelium-
dependent dilation in the presence of INDO and L-NAME. Likewise, inhibition of SOD-1 
with DETCA, augmentation of SOD with the cell permeable polyethylene-glycolated-SOD 
(PEG-SOD), and inhibition of endogenous CAT with AT did not alter the 3NP component of 
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mesenteric artery dilation, suggesting that endogenous H2O2 does not cause dilation. Even 
altering the CAT brand to mimic other studies where endogenous H2O2 acted as a dilator did 
not affect the ACh-induced dilation in this study. Although CAT inhibited dilation to 
exogenous H2O2, 1mmol/L H2O2 impaired the PGF2 -induced constriction following washout, 
suggesting that H2O2 causes damage to the vessels at high concentration that could be 
mistaken for dilation. Further studies in catalase-over-expressing (CAT
++
) mice suggest that 
H2O2 may not be a simple endothelium-dependent dilator in the same manner as NO. 
Suvorava et al (2005) observed that CAT
++
 mice were hypotensive compared to their 
catalase-negative (CAT
n
) counterparts, and that the addition of AT to CAT
++
 caused a 
normalization of blood pressure to the levels of CAT
n
. Interestingly, aortic endothelium-




; and H2O2 
caused endothelium-independent constrictions that were greater in the CAT
n
 strain. Thus, 
these findings suggest that H2O2 does not act as an endogenous dilator, but rather as an 
endothelium-independent constrictor leading to hypertension. Other studies in humans and 
other mammals suggest that H2O2 may not be involved in 3NP-mediated dilation. CAT does 
not inhibit the 3NP component of endothelium-dependent dilation in the radial arteries of 
coronary artery bypass patients (Hamilton et al, 2001). Similarly, co-incubation with CAT 
and SOD does not alter the 3NP component of dilation of coronary vessels to BKY in the 
Wistar rat perfused heart model (Fulton et al, 1997). Finally, incubation with CAT alone does 
not alter endothelium-dependent dilation or hyperpolarization of pig coronary arteries to BKY 
or Substance P (Bény and von der Weid, 1991). Thus, a wide body of evidence refutes the 
hypothesis that H2O2 is involved in 3NP-mediated dilation. 
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VASCULAR FUNCTION AND HYPERTENSION. 
It is generally agreed that agonist-induced increases in intracellular calcium levels in 
endothelial cells lead to the activation of eNOS and COX, causing the release of NO and PGs 
respectively, that cause dilation (McGuire et al, 2001). Factors distinct from NO and PGs are 
also released from the endothelium to cause dilation (McGuire et al, 2001). All of these 
endothelium-derived relaxing factors are altered in hypertension leading to impaired vascular 
function.   
 
A) NO-bioavailability and Hypertension  
Elevated ROS in hypertension can impair NO-bioavailability leading to vascular 
dysfunction (Rathaus and Bernheim, 2002; Paravicini and Touyz, 2006; Ardanaz and Pagano, 
2006). Renal hypertension is associated with a decrease in NO provision leading to impaired 
endothelium-dependent relaxation of blood vessels (Stankevicius et al, 2002) and complete 
blockade of NOS with chronic LN administration causes significant hypertension (Sainz et al, 
2005). In the spontaneously hypertensive rat (SHR) and in aortic banding hypertension, O2
-
 is 
elevated and endothelium-dependent dilation is impaired (Chu et al, 2003; Bouloumie et al, 
1997). The increased O2
-
 can interact with NO to create an elevated ONOO
-
, thereby causing 
nitrosylation and damage of proteins as well as reduced NO available for dilation (Bouloumie 
et al, 1997). Thus impaired NO-bioavailability may be important in hypertension. 
 
B) The PG Pathway and Hypertension  
The PG pathway is also involved in hypertension. PGs are endothelium-derived 
constricting and relaxing factors formed by the COX enzymes from arachidonic acid 
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(McGuire et al, 2001) and are inhibited by INDO (Kodama et al, 1995; Ruiz et al, 1994). 
INDO improves endothelium-dependent dilation to ACh and reduces receptor-dependent 
constriction to norepinephrine (NEPI) in the mesentery of SHR rats without altering either 
response in WKY (Luscher et al, 1990). In addition, INDO does not alter endothelium-
independent dilation to sodium nitroprusside (SNP) (Luscher et al, 1990) and has been shown 
not to alter LN-induced hypertension in SHR (Ruiz et al, 1994), suggesting that 
vasoconstricting PGs are produced in SHR rats thereby impairing vascular function without 
altering NO-bioavailability.  
 
C) 3NP-mediated Dilation and Hypertension 
Like NO and PGs, the remaining 3NP component of dilation may be altered in 
hypertension. SHR femoral arteries have reduced 3NP-mediated dilation at 15 and 25wks of 
age corresponding to the development of severe hypertension (Mori et al, 2006). In the 
mesenteric vessels, SHR have both impaired ACh-induced hyperpolarization and only ~10% 
dilation that is 3NP-mediated compared to ~55% in WKY (Fujii et al, 1992). Conversely, 
Sprague-Dawley (SD) rats fed high (8%) salt diets developed significant hypertension; 
however, the 3NP component of ACh-induced dilation is 81% in the high salt rats and only 
44% in the low salt (0.4%) group (Sofola et al, 2002). Thus, hypertension may involve the 
impairment of endothelium-dependent dilation through reduced dilation via the NO and PG 
pathways as well as reduced 3NP-mediated dilation. The effects on specific pathways depend 




H2O2 AS A COMPENSATORY DILATOR IN HYPERTENSION. 
The phenomenon of endogenous H2O2 as a dilator may compensate for reduced NO-
bioavailability. The injection of ecSOD into two-kidney one-clip ecSOD knockout (ecSOD
-/-
) 
mice causes an improvement in endothelium-dependent dilation in the aorta which may be 
due to augmented H2O2 since the administration of CAT caused complete inhibition of 
dilation in all groups (Jung et al, 2003). TEMPOL reduces LN induced hypertension in Wistar 
rats possibly through greater H2O2 instead of reduced O2
-
 since the increased activity of SOD-
1, SOD-2, GPx, and glutathione reductase enzymes following LN administration are reduced 
to normal levels in the kidney with TEMPOL treatment (Sainz et al, 2005). These findings 
suggest that the reduction in the SOD enzymes may be due to the presence of TEMPOL; 
however, the reduction in the endogenous H2O2 scavenging enzymes may suggest that the 
accumulated H2O2 following TEMPOL treatment may contribute to the reduction in blood 
pressure. Hatoum et al (2005) demonstrated that ACh caused CAT-sensitive endothelium-
dependent H2O2 production in human mucosal arteries only in the presence of LN and INDO 
and not with ACh alone, suggesting that H2O2 production may compensate for inhibited NO 
and PG production in the endothelium. The inability of CAT to inhibit dilation to ACh in the 
absence of LN and INDO is supported by several other studies (Matoba et al, 2000; Beny and 
von der Weid, 1991). Thus, endogenous H2O2 may compensate for a decrease in NO-
bioavailability in hypertension. 
Nevertheless, several studies suggest that endogenous H2O2 does not compensate for 
reduced NO. CAT does not alter ACh-induced dilation in the femoral arteries of 15wk old 
WKY in the presence of LN and INDO and who have a blood pressure of 125mmHg, 
suggesting that H2O2 does not contribute to 3NP mediated dilation in normotensive animals 
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(Mori et al, 2006). Similarly, Fujiki et al (2005) describe an increase in the CAT-sensitive 
3NP component of dilation in normotensive (SBP=116mmHg) mouse mesenteric arteries 
following treatment with an ACE-inhibitor and suggest that this treatment rather than the 
increased blood pressure causes greater H2O2-mediated dilation. Finally, the injection of 
TEMPOL along with the SOD-inhibitor DETC causes an increase in blood pressure, likely 
through increased endogenous H2O2, which is normalized by the addition of CAT (Makino et 
al, 2003). Thus, several groups suggest that H2O2 does not compensate for reduced NO, and 
may instead cause hypertension.  
 
PURPOSES. 
The following study aims to investigate the role of endogenous H2O2 as a 3NP-mediated 
dilator in resistance arteries, and the extent of the contribution of endogenous H2O2 to dilation 
in hypertension. This study will investigate the effect of CAT on the function of rat 
mesenteric arteries and how the CAT effect changes with hypertension. The response of 
mesenteric arteries to exogenous H2O2 will also be assessed. The SOD-mimetic TEMPOL 
will be acutely administered to both hypertensive and normotensive arteries and changes in 
vasomotor function will be measured. Finally, the level of H2O2 released from the vessel 
under myography conditions will be measured using a fluorescent probe.  
The contribution of endogenous H2O2 to vasodilation has been supported and refuted by 
numerous studies, and the contribution of this ROS in rat resistance arteries has not been 
established. In addition, hypertension may increase or decrease the 3NP component of 
dilation, but the role of H2O2 in 3NP dilation is unknown. The following study aims to 
address the controversial role of endogenous H2O2 as a 3NP-mediated dilator, the dependence 
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of the endothelium on this response, and how endogenous H2O2-mediated dilation is altered 
with hypertension and antioxidant treatment. 
 
HYPOTHESES. 
Hypothesis 1: SHR vessels will exhibit reduced endothelium-dependent dilation, a reduced 
3NP component, with normal vascular smooth muscle dilation and exaggerated constrictory 
functions when compared to WKY.  
Hypothesis 2: CAT will inhibit 3NP-mediated dilation in SHR rats but not in WKY and will 
not affect dilation or constriction in the absence of NO and PG blockade. ACh will cause an 
increase in vascular H2O2 accumulation that is sensitive to CAT. 
Hypothesis 3: Exogenous H2O2 will cause both constriction and dilation in both SHR and 
WKY vessels, depending on the concentration of H2O2. 
Hypothesis 4: TEMPOL will improve both the NO and the 3NP components of endothelium-
dependent dilation and the improvement will be greater in SHR than WKY. The improvement 
in 3NP with TEMPOL will be eliminated with CAT. 
Hypothesis 5: In isolated vessels, CAT will reduce H2O2 release while TEMPOL will increase 
H2O2 release in a CAT sensitive manner. Vessels stimulated with ACh in the presence of NO 







Figure 1: H2O2 in 3NP-mediated dilation. Arrows indicate activation of an enzyme or 
formation of ROS. T-bars indicate inhibition of a cellular pathway (i.e. inhibited Ca
2+
-influx 
















 Male SHR (n=60) and male Wistar Kyoto rats (WKY, n=47) were obtained 
from Harlan (Indianapolis, IN) at ~12weeks of age. Male Sprague Dawley rats (SD, n=29) 
were obtained from the University of Waterloo breeding colony. Rats were group housed in a 
temperature and humidity controlled room and acclimatizing to the reverse light cycle. Rats 
were fed standard rat chow (Harlan) and tap water ad libitum. At 16-20weeks of age, rats 
were injected with sodium pentobarbital in saline (~85mg/kg i.p.; Bimeda-MTC, Cambridge, 
ON). For measurements of hemodynamics, the level of sedation was monitored through the 
withdrawal reflex from a toe pinch, and sodium pentobarbital was additionally titrated at to 
ensure withdrawal reflex was absent and breathing rate was regular during measurements. 
Following measurement of hemodynamics, the rats were sacrificed by exsanguination and the 
mesentery was removed. All drugs were obtained from Sigma Chemical (St. Louis, MO) 
except for NaHCO3 (BioShop; Burlington, ON).  
 
HEMODYNAMIC MEASURES. 
Blood pressure was directly assessed through the left carotid artery of a subset of rats 
(WKY; n=22, SHR; n=24). Anaesthetized rats were placed supine on a heating pad at 37°C 
(Gaymar TP-500, Orchard Park, New York and Temp-Pad; Seabrook Medical Systems). 
Following an incision into the neck, the left carotid artery was exposed and a small cut was 
made in the artery. The calibrated catheter (size 2F, 140cm: Millar Instruments, Houston, TX) 
was inserted into the artery, oriented towards the heart, and secured with silk suture (4-0 silk, 
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Look, Reading, PA). The systolic blood pressure (SBP), diastolic blood pressure (DBP), mean 
arterial pressure (MAP) and heart rate (HR) outputs were registered on a Powerlab console 
(ADInstrumetnts, Colorado Springs, CO) using Chart 5 software (ADInstruments, Colorado 
Springs, CO, v5.5.4). 
 
ASSESSMENT OF VASOMOTOR FUNCTION. 
A) Surgery 
  A section of the small intestine spanning from the pylorus to the proximal large 
intestine was removed, and was immediately placed in oxygenated (95%O2/5%CO2) 
physiologic salt solution (PSS; concentration (mmol/L): 118.99NaCl, 4.69KCl, 
1.17MgSO4 7H2O, 1.18KH2PO4, 2.50CaCl2 2H2O, 25.00NaHCO3, 0.03EDTA, 5.50Glucose) 
at 4°C. The intestine was pinned about the perimeter of a surgery dish embedded with silicone 
elastomer (Sylgard 184, Dow Corning Inc, Midland, MI) with the mesenteric arcades splayed. 
The superior mesenteric artery was identified and the 3
rd
 order artery branches were cleaned 
of venous branches under a microscope (Zeiss; VWR, Mississauga, ON). A single 3
rd
 order 
artery was divided into two segments for mounting to the myograph, and a neighboring 3
rd
 
order artery was used as an alternate. All vessels were placed into oxygenated PSS at room 
temperature (22°C) and then mounted onto the calibrated single wire myograph (model 310A, 
DMT, Aarhus, Denmark) in a chamber filled with 10mL 37°C oxygenated PSS as outlined by 
Mulvany and Halpern (1977). Briefly, two adjacent horizontal wires were carefully threaded 
through the lumen of the artery and secured to adjacent steel jaws. One jaw was directly 
connected to a force transducer, while the other was attached to a micrometer, allowing the 
distance between the adjacent wires, and hence the vessel lumen diameter and wall tension, to 
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be adjusted. Output from the force transducer was linked to a personal computer through a 
Myo-Interface unit (model 310A, v2.03) attached to a Powerlab console.  
 
B) Vessel Preparation for Myography Experiments 
 Each excised vessel was subjected to normalization and standard start protocols 
following by a defined experimental protocol. 
 
 I) Normalization protocol 
 Following mounting, the vessels were incubated for 30min in 37°C PSS with bubbled 
95%O2/5%CO2 prior to normalization. The normalization procedure involved the stepwise 
increase in diameter increments of 10μm/min to a maximal tension of 10mN as outlined by 
Mulvany and Halpern (1977). The normalized diameter (Lo) was derived from the intersect of 
the 100mmHg isobar (the tension required to elicit a pressure of 100mmHg), and the vessel 
wall tension was set in accordance with the LaPlace relationship (pressure=wall 
tension/(internal circumference/2 )) for each vessel for the remainder of the protocol. 0.9Lo 
was used as the experimental diameter as it has been established as the diameter that elicits 
the greatest active tension in studies by Falloon et al (1995), as well as by our own pilot work. 
 II) Standard Start Protocol 
 Following incubation, the normalized vessel underwent a standard start protocol 
involving the exchange of bathing solutions containing 1) 10mL potassium physiologic salt 
solution (KPSS; concentration: substitutes 123.70mmol/L total KCl for KCl+NaCl in PSS) 




mol/L NEPI in PSS only, 3) and KPSS only, for 
3min respectively. Exposure to each solution was followed by 4 exchanges with PSS. After 
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the last wash, the endothelium function test was performed and both vessels were incubated 
with 3μmol/L (+/-)-Propranolol hydrochloride (propranolol, abbreviated PRO) to block the ß-
adrenergic receptor mediated effects of NEPI (Yang et al, 2005; Mulvany et al, 1982). In 
addition to PRO, some vessels were incubated with the following drugs: 1) Catalase (CAT, 
860U/mL; from bovine liver, 2) 4-Hydroxy-TEMPO (TEMPOL; 1mmol/L), 3) N -nitro-L-
arginine methyl ester hydrochloride (L-NAME, abbreviated to LN; 300μmol/L), 4) 
Indomethacin (INDO; 5μmol/L ).  
The dose of LN (300μmol/L) was similar to the dose commonly used in our lab 
(100μmol/L). 300μmol/L LN has been shown to inhibit dilation in SD rat small mesenteric 
vessels, an effect that was not altered by the additional administration of other NOS 
inhibitiors or the soluble guanylate cyclase (sGC) inhibitor (Chauchan et al, 2003), suggesting 
that 300μmol/L LN is sufficient to inhibit NOS in this preparation. Similarly, our lab and 
others use 5μmol/L INDO to inhibit COX-mediated vasomotor function in the mesenteric 
arteries of SHR, WKY and SD rats (Chauhan et al, 2003; Le Marquer-Domagala and Finet, 
1997). Finally, in studies demonstrating the role of H2O2 as an endogenous vasodilator, the 
concentration of NOS inhibitor was 100μmol/L and the concentration of COX-inhibitor was 
1μmol/L (Matoba et al, 2000, 2003; Morikawa et al, 2003), and closely match the doses used 
in the present study. 
 Similarly, the dose of TEMPOL and CAT were taken from findings in the literature. 
1mmol/L TEMPOL has previously been shown to cause a dilation in vessels that was 
reversed by CAT in rat mesenteric arteries (Chin et al, 2007). 860U/mL of CAT was chosen 
to approximate the 1000U/mL shown to eliminate H2O2-induced dilation and constriction to 
10
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mol/L H2O2 in both WKY and SHR (Gao and Lee, 2001). Similarly, 1250U/ml CAT from 
bovine liver has been shown to greatly inhibit ACh-induced dilation in mouse small 
mesenteric arteries in the presence of LN and INDO (Matoba et al, 2000), suggesting that 
860U/mL would be sufficient to reveal an effect of endogenous H2O2 on vasodilation in our 
preparation. 
 
C) Myography Experimental Protocols 
 I) Denuding protocol and endothelial function test 
 Selected SD vessels (n=12) were denuded by rubbing the lumen for 1min with straight 
human hair, as described by Mulvany (2004). Following denudation, the vessel normalization, 
standard start, and experimental protocols proceeded as usual.  
The endothelial function test was performed in all rat strains (SHR, WKY, SD) and 
followed the standard start protocol. This procedure consisted of a 10
-5
mol/L NEPI pre-





stimulate endothelium dependent dilation. Following the application of ACh, the bathing 
solution was exchanged 4x with PSS and PRO was re-administered. 
 
II) KCl dose-response curve 
 The KCl dose-response curve consisted of the equimolar replacement of KCl for NaCl 
(0-100mmol/L KCl in 10mmol/L increments, see Appendix A for solution preparation) in the 
constant presence of PRO, and in the presence or absence of CAT, TEMPOL, LN, or INDO. 
The equimolar replacement of KCl for NaCl ensured that the effects were due to changes in 
K
+
 but with a constant total ionic concentration. The solution bathing the vessel was removed 
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and replaced with each subsequent KCl solution. Following the final dose of the KCl dose-
response curve, the bathing solution was exchanged 3-4x with PSS and the inhibitors were 
replaced. 
 
III) NEPI and H2O2 Constriction Dose-Response Curves 
The constriction curves were preceded by 15-30min incubation with selected 










 mol/L and half-concentrations) revealed the effect of H2O2 in a 
quiescent vessel. Developed tension was calculated as the difference between peak 
constriction and baseline (in mN). Following the response from the final dose of either 
agonist, baths were replaced 3-4x. 
 
IV) ACh, SNP, and H2O2 Dilation Dose-Response Curves 





 mol/L and half-concentrations) measured endothelium-dependent dilation and a 




 mol/L and half-concentrations) measured endothelium-




 mol/L and half-concentrations) 
was also conducted on selected vessels. All dose-response curves were preceded by 15-30min 
incubation with selected inhibitors (PRO, LN, INDO, CAT, TEMPOL). The vessels were pre-
constricted with 10
-5
mol/L NEPI and the dilation curve began once a plateau in the 
constriction was achieved. The peak dilation response was used to calculate the change in 
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tension from the NEPI pre-constriction plateau and was expressed as % dilation. Following 
the response from the final dose of agonist baths were replaced 3-4x.  
 
V) Tempol and Catalase experiment 
 The TEMPOL and CAT experiment occurred following a 15min incubation in PSS 
containing PRO and simulated an experiment performed by Chen et al (2007) in rat 
mesenteric arteries. The vessels were pre-constricted with 10
-5
mol/L NEPI and 1mmol/L 
TEMPOL was added causing dilation to a plateau over 20-30min. Once the plateau was 
achieved, 860U/mL CAT was added and a reconstriction was measured over 10-20min. 
1mmol/L TEMPOL was present in the CAT solution in order to maintain the TEMPOL 
concentration and the plateau dilation and constriction response were calculated (in mN). 
 
H2O2 ACCUMULATION 




 order) were obtained as described above and 
kept in PSS at 4°C. Groups of mesenteric arcades with equal weight (1-3arcades/treatment) 
were incubated in 200μL volumes of 37°C PSS, or with PSS containing ACh (10-4mol/L), LN 
(300μmol/L), INDO (5μmol/L), CAT (860U/mL), and TEMPOL (1mmol/L) alone or in 
combination. Each vessel group, and non-vessel blank solutions, were incubated with 200uL 
volumes of the fluorescent probe 10-acetyl-3,7-dihydroxyphenoxazine (Amplex Red; 10 
μmol/L,) and horseradish peroxidase (0.2U/mL) dissolved in PSS as a stock solution for 1hr 
at 37°C in the dark in brown tubes. The Amplex Red Assay reagents and H2O2 standards were 
purchased in a Amplex Red Hydrogen Peroxide/Peroxidase Assay Kit (Molecular Probes, 
Invitrogen Detection Technologies, Eugene, OR) and the reagent concentrations were chosen 
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to limit autofluorescence (Dikalov et al, 2007). Following incubation, the solutions were 
mixed and the supernatant was aliquoted in triplicates of 100μL into a 96well dark plate. 
Fluorescence of supernatant was measured on a fluorescent spectrometer (SpectraMax 
GeminiXS, Molecular Devices, Sunnyvale, CA), and H2O2 concentration was obtained from a 





Following removal of the supernatant for H2O2 measurement, the vessels were 
washed, snap-frozen in liquid nitrogen, removed from tubes, and hand homogenized with a 
glass homogenizer (Kontes-Glass, Vineland, NJ) in 100uL of lysis buffer (20mM Hepes, 
10mM NaCl, 1.5mM MgCl, 1mM DTT, 20% Glycol, 0.1% Triton X 100) with protease 
inhibitor (40μL/mL, Complete, Roche, Basel, Switzerland). Aliquots were then incubated at 
37°C at 350rpm for 3hrs. Protein concentration was measured using a BCA assay (see 
Western protocol). H2O2 concentration was normalized to the protein content of tested vessel 
homogenates and expressed as pmol/mg protein.  
 
WESTERN BLOTTING. 
 Frozen vessel segments (1-3segments of 3-5mg) were thawed and homogenized as 
described above and homogenates were combined for each rat. Protein concentration was then 
assessed using the BCA protein assay method where samples were combined with BCA 
working reagent (50parts bicinchoninic acid + 1 part Copper II sulphate) and compared to a 
bovine serum albumin protein standard. The protein concentration was read on a spectrometer 
(OD 527nm, SpectraMax plus 384, Molecular Devices, Sunnyvale, CA).  
 Each homogenate was aliquoted into individual samples for westerns to reduce the 
impact of freezing and thawing the stock homogenate for each western. Samples were 
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prepared with  of the total volume of sample buffer (see Appendix A) and with protein 
diluted to 1μg/μL in lysis buffer to ensure equal loading. 
 A glass plate sandwich was loaded with 5-15% running gel and stacking gel. Samples 
were thawed, denatured at 95°C for 2-5min and loaded to randomly assigned lanes along with 
a rainbow (3-6μL GE Healthcare, Buckinghamshire, UK), a biotin ladder (3-8μL, Cell 
Signaling, Danvers, MA), and a protein standard (SHR mesenteric artery homogenate). The 
gel was electrophoresed for 30-60min at 175V using electrophoresis units (Bio-Rad, 
Mississauga, ON). For high molecular weight proteins (COX-1 and eNOS), non-methanol 
transfer buffer was used, and transfer buffer containing methanol was used for all other 
proteins (Appendix A). The gels were then transferred to the membrane at 25V for 45min. 
Following the transfer, the membrane could be dried or stained with Ponceau to expose 
protein loading.  
 For immunodetection, membranes were blocked for 1-3hrs in 10% milk or 5%BSA 
dissolved in TBS-T to block non-specific biding sites, and subsequently incubated for 1-12hrs 
with a primary antibody for Catalase (Chemicon, Danvers, MA), COX-1 (Cayman, Ann 
Arbor, MI), p47phox (Transduction Laboratories, BD, Mississauga, ON), SOD-1 (Stressgen 
Biotechnologies, Ann Arbor, MI) and SOD-2 (Stressgen Biotechnologies, Ann Arbor, MI).  
The membranes were then washed in TBST and exposed to the appropriate horseradish-
peroxidase conjugated secondary antibody for 1hr (Santa Cruz Biotechnologies, Santa Cruz, 
CA). The membranes were washed again and exposed to the ECL detection solution (1:1, GE 
Healthcare, Buckinghamshire, UK) and developed in a Syngene Bio-imaging system 
(Cambridge, UK). Samples were run in duplicate and the average response for each rat was 
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averaged across the strain. Results were compared using a Student t-test with p<0.05 
considered significant. 
 
DATA FILTERING AND STATISTICAL PROCEDURES 
 To eliminate the high frequency but low amplitude force oscillations in dose-response 
curves, the data was filtered with a 0.1Hz low-pass filter with a 0.02Hz transition width. The 
responses of interest remained generally unchanged by the filtering, but this procedure 
eliminated the oscillations from contributing to changes in peak responses.  
 For constrictor curves (NEPI and H2O2), data was calculated as developed tension 
(peak constriction – resting tension). For dilation curves (ACh, SNP, H2O2), data was 
calculated as peak %dilation ((peak dilation/plateau in pre-constriction) x 100). For the dose-
response curves, the curve parameters were calculated using a sigmoidal model with the 
bottom set to 0 (GraphPad Prism, v5.0a, San Diego, CA). Maximum Constriction (MC, in 
mN), Maximum Relaxation (MR, in %), sensitivity (EC50, in mol/L or log mol/L), and total 
area-under-the-curve (AUC, in arbitrary units (AU)) were calculated for each artery.  
The preconstrictions and parameters of the dose-response curves were compared with 
a 2-way ANOVA (rat strain vs drug condition,  = 0.05) using SPSS statistical software 
(v16.0, SPSS Inc, Chicago, IL). The rat tissue weights, hemodynamic measures, intact vessel 
H2O2 production, and vessel characteristics were also compared using a 2-way ANOVA. In 
the event of a significant interaction, a one-way ANOVA was run for each strain (where  = 
0.05/#strains) and a LSD post-hoc test was completed (  = 0.05). A Student T-test for 
independent means compared differences between strains from the 2-way ANOVA (  = 
0.05/#drug conditions). For Western blots, SD experiments, and wherever appropriate, 
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RAT AND ARTERY BASELINE PARAMETERS. 
As anticipated, the SHR had an elevated blood pressure and heart rate compared to 
WKY (Table 1B).  In addition, the SHR had greater body weight and an increased absolute 
heart and kidney weight; however, only the left kidney-to-body weight ratio was different 
between strains (Table 1A). For the vessel parameters, there was no difference in normalized 
vessel diameter between strains; but, as expected, there was a ~50-60% reduction in dilation 
to 10
-4
mol/L ACh in the endothelial function test in SHR compared to WKY (Table 1C). In 
WKY, HR was significantly correlated to MAP (r= 0.853, p<0.001), SBP (r=0.794, p<0.001) 
and DBP (r=0.868, p<0.001) but no other correlations existed between LK/BM, endothelial 
function test (%), and BP parameters. In addition, no correlations existed between BP 
parameters, LK/BM, endothelial function test (%), or HR in SHR.  
 
VASORELAXATIONS. 
A) Endothelium-dependent vasomotor function – ACh dose-response curves 
I) Preconstrictions 
Differences in preconstrictions were noted prior to the ACh dose-response curves. When 
collapsed across strain, CAT incubation caused a decrease in preconstriction (7.5±1.5mN, 
n=12, p=0.044), and TEMPOL CAT LN INDO caused an increase in preconstriction 
(15.9±1.2mN, n=16, p=0.001) when compared to CON (11.0±0.7mN, n=72); however, no 
differences were noted between strains (Table 2A-D). In addition, preconstriction prior to 
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CAT LN INDO did not differ from CON (p=0.850), LN INDO did not differ from CON 
(p=0.907), and CAT LN INDO did not differ from LN INDO (p=0.936).  
 
II) Maximal Responses, Sensitivity and Total Responses to ACh 
Endothelium-dependent dilation was modulated both by condition and by the rat strain 
(Table 2A-D, Figures 2-4). For simplicity, the maximal responses and logEC50 will be 
described for differences between conditions and strains. Since changes in AUC were 
comparable to changes in maximal dilation, AUC will be mentioned only when these 
parameters do not follow the same pattern.  
 
III) Comparison of control group responses and LN and INDO treatments 
Both the maximum response and total response of SHR vessels was ~20% less than 
WKY under CON conditions (p<0.001, p<0.001) (Table 2B, Figure 2). LN inhibited both 
SHR and WKY responses (SHR: p<0.001, WKY: p=0.012), while INDO improved maximal 
dilation in SHR only (SHR: p=0.023, WKY: p=0.287) (Figure 2). However, AUC in WKY 
was increased by INDO compared to CON (p=0.031) (Table 2B). Although, maximal dilation 
was greater in WKY CON than SHR INDO (p<0.001), the AUC was no different (p=0.448). 
Co-incubation with LN and INDO inhibited ~38% of maximal dilation from CON (p<0.001) 
in SHR. In addition, in SHR, LN INDO had greater maximal dilation (p=0.001) than LN. 
Conversely, in WKY, LN INDO did not alter dilation from CON (p=0.287), but did improve 




IV) Comparison of responses with CAT treatment 
Incubation with CAT did not alter dilation from CON in WKY (p=0.124) or SHR 
(p=0.985) (Table 2B-C, Figure 3). Co-incubation with CAT LN INDO caused further 
inhibition in maximal dilation from LN INDO; however, this response only tended towards 
significance in SHR (p=0.062 in ANOVA, p=0.041 in Student T-test), while achieving 
significance in WKY (p=0.013). However, AUC measures revealed no difference between 
CAT LN INDO and LN INDO in WKY (p=0.313). Interestingly, the maximal response with 
CAT LN INDO treatment was no different from LN in SHR (p=0.517) and WKY (p=0.457). 
 
V) Comparison of responses with TEMPOL treatment 
Incubation with TEMPOL did not alter dilation from CON in SHR (p=0.160) or WKY 
(p=0.928) (Table 2A and D, Figures 2 and 4), but TEMPOL did enhance the reconstriction 
phase in SHR. In both SHR and WKY, co-incubation with TEMPOL LN INDO did not alter 
dilation from LN INDO (SHR: p=0.129, WKY: p=0.377), from CON (SHR: p=0.081, WKY: 
p=0.920), or from TEMPOL CAT LN INDO (SHR: p=0.506, WKY: p=0.866). However, in 
contrast to the aforementioned maximal response measures, TEMPOL LN INDO in SHR 
yielded a lower AUC than SHR CON (p=0.017). Finally, TEMPOL CAT LN INDO had 
reduced dilation from CON in SHR (p=0.001) but not in WKY (p=0.751).  
Following co-incubation with TEMPOL CAT LN INDO in WKY, both maximal 
dilation and AUC was no different from CAT LN INDO (p=0.353, p=0.366); however, in 
SHR, TEMPOL CAT LN INDO caused greater preconstriction, maximum dilation, and AUC 
than CAT LN INDO (p=0.009; p=0.009; p=0.008).  
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B) Endothelium-independent vasomotor function – SNP dose-response curves 
I) Preconstrictions 
Endothelium-independent responses were assessed by an SNP dose-response curve in 
NEPI preconstricted vessels (Table 3 A-D, Figures 5-7). Preconstriction was greater in SHR 
than WKY when collapsed across all drug conditions (WKY: 10.6±0.7mN (n=56) vs SHR: 
13.3±0.7mN (n=67)); however, there was no main effect of drug condition on preconstriction; 
and NEPI preconstriction was not significantly different between SHR CON and WKY CON. 
The preconstrictions preceding the first and second dilatory dose-response curves, in the 
absence of inhibitors, were highly correlated in both WKY CON (PC1: 12.6+/-1.1mN vs PC2: 
13.7+/-0.9mN (n=15), r=0.761, p=0.001) and SHR CON (PC1: 9.5+/-1.5mN vs PC2: 8.8+/-
1.4mN (n=15), r=0.946, p<0.001).  
 
II) Maximal Responses, Sensitivity and Total Responses to SNP 
Maximal responses to the endothelium-independent dilator SNP were no different 
between SHR and WKY; however, there was a main effect of drug condition (Table 3A). The 
main effect of rat strain was also found for AUC, where SHR had ~6% greater total response 
than WKY when collapsed across drug conditions (423.0±5.2 vs 399.6±6.6). Similarly, there 
was a main effect of rat strain on logEC50 where SHR were slightly, but significantly, more 
sensitive to SNP than WKY when collapsed across drug conditions          (-8.5±0.6 vs -
8.3±0.1log mol/L). In addition to the main effects of strain, there was also a main effect of 




III) Comparison of control group responses and L-NAME and INDO treatments 
There were no interaction effects for maximal relaxation, logEC50, and AUC, so only 
the main effects of drug condition have been described (Table 3A). Incubation with LN did 
not alter the maximal response, AUC, or logEC50 from CON (p=0.925; p=0.340; p=0.436) 
(Table 3B, Figure 5). Similarly, incubation with INDO did not alter maximal response, AUC, 
or logEC50 from CON (p=0.206; p=0.088; p=0.240). However, co-incubation with LN and 
INDO caused a greater maximal response (p=0.037) and AUC (p=0.009) compared to CON 
with unchanged sensitivity (p=0.140). 
 
IV) Comparison of responses with CAT treatment 
There were no interaction effects for maximal relaxation, logEC50, and AUC, so only 
the main effects of drug condition have been described (Table 3A). Incubation with CAT did 
not alter maximal response to SNP (p=0.255), AUC (p=0.953), or logEC50 (p=0.896) from 
CON (p=0.255, p=0.953, p=0.896) (Table 3C, Figure 6). In addition, co-incubation with CAT 
LN INDO did not alter maximal response, AUC, or sensitivity from LN INDO (p=0.532, 
p=0.259, p=0.080). CAT LN INDO treatment had greater maximal response (p=0.049), AUC 
(p=0.001), logEC50 (p=0.003) than LN, regardless of strain. 
 
V) Comparison of responses with TEMPOL treatment 
There were no interaction effects for maximal relaxation, logEC50, and AUC, so only 
the main effects of drug condition have been described (Table 3A). Neither TEMPOL 
incubation nor TEMPOL LN INDO co-incubation altered maximal response, AUC, or 
sensitivity from CON (TEMPOL vs CON: p=0.068, p=0.718, p=0.613; TEMPOL LN INDO 
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vs CON: p=0.080, p=0.976, p=0.336) (Table 3D, Figure 7). Similarly, TEMPOL LN INDO 
was no different from LN INDO or from TEMPOL CAT LN INDO for maximal response, 
AUC, or sensitivity (TEMPOL LN INDO vs LN INDO: p=0.724, p=0.088, p=0.139; 
TEMPOL CAT LN INDO vs TEMPOL LN INDO: p=0.243, p=0.252, p=0.384). 
Interestingly, TEMPOL CAT LN INDO had lower AUC than CAT LN INDO 
(p=0.039) and a decrease in sensitivity (p=0.006) but no difference in maximal relaxation 
(p=0.851). In addition, TEMPOL LN INDO had a decreased sensitivity and AUC to SNP 




A) Receptor-mediated Constriction – NEPI dose-response curves 
I) Maximal responses, Sensitivity and Total Responses to NEPI 
 Receptor-mediated constriction was assessed by the NEPI dose-response curve in the 
presence of the -blocker PRO. Main effects for rat strain and drug condition were observed 
for the maximal constriction response, where the SHR had ~23% greater constriction than 
WKY when collapsed across drug conditions (13.4±0.6mN vs 10.9±0.6mN) (Table 4A, 
Figures 8 and 9). Similar to maximal constriction, AUC analysis showed a main effect of both 
rat strain and drug condition, where SHR had ~21% greater AUC than WKY (46.4±2.0 vs 
38.5±2.2). For logEC50, there was an interaction effect of rat strain*drug condition but 





II) Comparison of control group responses L-NAME and INDO treatments 
There were no interaction effects for maximal constriction, logEC50, and AUC, so only the 
main effects of drug condition have been described (Table 4A). INDO did not alter maximal 
response or AUC from CON (p=0.883, p=0.606) or from LN INDO (p=0.472, p=0.362) 
(Table 4B, Figure 8-9). In addition, maximal constriction and AUC for LN INDO was no 
different from CON (p=0.406, p=0.477), irrespective of strain. 
 
III) Comparison of responses with CAT and TEMPOL treatments 
There were no interaction effects for maximal constriction, logEC50, and AUC, so only 
the main effects of drug condition have been described (Table 4A). The maximal contraction 
and the AUC in the presence of TEMPOL were no different from CON (p=0.145, p=0.230) 
(Table 4C, Figure 8-9). In addition, the maximal contraction and the AUC in the presence of 
CAT LN INDO were no different from LN INDO (p=0.808, p=0.754). Interestingly, 
treatment with TEMPOL CAT LN INDO increased the maximal response and AUC above 
CON (p=0.001, p=0.001), LN INDO (p=0.037, p=0.023), and CAT LN INDO (p=0.049, 
p=0.035) regardless of strain.  
  
B) Electromechanical coupling – KCl dose-response curve 
I) Maximal responses, Sensitivity and Total Responses to KCl 
Electromechanical coupling was assessed using a KCl dose-response curve with a 
equimolar exchange of KCl for NaCl. No significant main or interaction effects were 
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observed for maximal constriction; however, a main effect of drug condition was observed for 
both AUC and EC50 (Table 5A). 
 
II) Comparison of control group responses and L-NAME and INDO treatments 
 There were no interaction effects for maximal relaxation, EC50, and AUC, so only the 
main effects of drug condition have been described for AUC and EC50 (Table 5A). INDO did 
not alter AUC or sensitivity compared to CON (p=0.845, p=0.846); however, LN INDO 
increased both AUC and sensitivity over CON (p=0.011, p<0.001) (Table 5B, Figure 10). 
Although AUC was not significantly different between INDO and LN INDO (p=0.063), EC50 
was improved in LN INDO compared to INDO (p=0.003).  
 
III) Comparison of responses with CAT and TEMPOL treatments 
There were no interaction effects for maximal relaxation, EC50, and AUC, so only the 
main effects of drug condition have been described for AUC and EC50 (Table 5A). For the 
CAT LN INDO condition, the AUC and EC50 did not differ from LN INDO (p=0.818, 
p=0.131) (Table 5C, Figure 11). In addition, TEMPOL did not alter AUC or sensitivity from 
CON (p=0.906, p=0.055). 
 
RESPONSES TO EXOGENOUS H2O2. 
 The response to exogenous H2O2 was assessed both in preconstricted and quiescent 
vessels in SHR and WKY (Table 6, Figures 12 and 20).  To illustrate the relationship between 
H2O2 constrictory and dilatory responses, H2O2-induced constriction in each SHR and WKY 
artery was expressed relative to the NEPI preconstrictions achieved in the endothelial function 
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test, and these results are illustrated in Figure 12 with error bars omitted for clarity (Figure 20 
is the same figure with the error bars).   The maximal relaxation, logEC50, and AUC did not 
differ between strains. However, the SHR preconstrictions were ~46% lower than the WKY 
vessels but did not achieve statistical significance. The maximal constriction, logEC50, and 
AUC did not differ between SHR and WKY in the H2O2 constriction curve from the quiescent 
state, which is expressed as developed tension in Table 7. In addition, the NEPI reconstriction 
that followed either the H2O2 constriction or dilation dose-response curves did not differ 
between SHR and WKY, but was greatly blunted compared to the preconstrictions for the 
H2O2 dilation curve in both strains (p=0.001).  
 The ability of the endothelium to modulate the direct effects of H2O2 was assessed in 
both endothelium-intact (E+) and endothelium-denuded (E-) mesenteric arteries in SD rats. In 
addition, both E+ and E- vessels were pre-incubated with 860U/mL CAT to assess changes in 
the H2O2 dilatory response. Detailed descriptions of the results are included in Appendix B 
(Figure 21). Briefly, both E+ and E- vessels dilate with H2O2, but the AUC in E+ is ~40% 
greater than in E-. In addition, H2O2 to quiescent E+ and E- vessels causes a similar 
constriction. Finally, pre-incubation with CAT shifts both the E+ and E- curves to the right, 
and decreases the AUC by 55-75% without altering the maximal relaxation. 
 
VASCULAR H2O2 ACCUMULATION. 
A) Comparisons between rat strains 
Levels of H2O2 accumulated from intact vessels were measured using the Amplex Red 
Assay (WKY n=5-6/group; SHR n=7-8/group). There was an interaction effect for H2O2 
accumulation (strain*condition: p=0.050). For the SHR, no differences existed for PSS or 
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ACh standards between Basal and Stimulated groups (PSS-Basal vs PSS-Stimulated, 
p=0.219; ACH-Basal vs ACH-Stimulated, p= 0.407). Similarly, in isolated WKY mesenteric 
arteries, no differences existed for PSS or ACh standards between Basal and Stimulated 
groups (PSS-Basal vs PSS-Stimulated, p=0.178; ACH-Basal vs ACH-Stimulated, p= 0.055) 
Thus, for clarity, the PSS and ACh responses were collapsed across basal and stimulated 
experiments in the text and in Table 7A, and statistical tests reflected differences from the 
appropriate standard. 
Generally, no differences existed between strains, although there were significant trends 
approaching the p=0.05 significance level (Table 7A-C). Several trends favored the increased 
release of H2O2 by SHR vessels over WKY in the ACh (p=0.055), TEMPOL (p=0.055), and 
ACh TEMPOL (p=0.062) conditions. Conversely, there were trends towards reduced H2O2 
accumulation in SHR below WKY in the ACh CAT LN INDO (p=0.053) and CAT (p=0.057) 
conditions. Otherwise, there were no differences between strains (PSS p=0.174, LN INDO 
p=0.566, ACh LN INDO p=0.134, ACh -CAT p=0.425, CAT LN INDO p=0.166, ACh 
TEMPOL LN INDO p=0.983, TEMPOL CAT p=0.850, and ACh TEMPOL CAT LN INDO 
p=0.852).  
 
B) Comparison of control group responses and L-NAME and INDO treatment 
  ACh treatment did not stimulate H2O2 release in SHR vessels (p=0.147) and co-
incubation with ACh LN INDO did not alter H2O2 production from PSS (p=0.501) or from 
LN INDO (p=0.544), 
In isolated WKY mesenteric arteries, ACh does not stimulate H2O2 release over PSS 
in either (p=0.055) (Table 7A). In addition, ACh LN INDO did not release additional H2O2 
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when compared to PSS (p=0.084) or LN INDO (p=0.946), nor did LN INDO release H2O2 
when compared to PSS (p=0.098). 
 
C) Comparison of responses with CAT treatment  
In SHR vessels treated with CAT alone or in the presence of LN and INDO had 
reduced H2O2 production below PSS levels (CAT p<0.001, CAT LN INDO p<0.001, ACh-
CAT p=0.031, ACh CAT LN INDO p=0.003) (Table 7B). Also, the additional presence of 
ACh did not alter H2O2 production when co-incubated with CAT LN INDO (p=0.854) or with 
CAT (p=0.448). Notably, ACh CAT LN INDO had lower H2O2 release compared to ACh LN 
INDO (p<0.001) in SHR.  
In a similar pattern to SHR, WKY vessels treated with ACh and CAT either together 
or in combination LN and INDO reduced H2O2 release below PSS (ACh CAT p=0.043, CAT 
LN INDO p=0.032, ACh CAT LN INDO p=0.018) (Table 7B). In contrast to the SHR 
experiments, WKY vessels incubated in CAT alone did not have reduced H2O2 below the PSS 
condition (p=0.199). These results confirm that CAT scavenges H2O2 in isolated mesenteric 
arteries. 
 
D) Comparison of responses with TEMPOL treatment 
In SHR, TEMPOL alone did not increase H2O2 release over PSS (p=0.879) (Table 
7C). ACh TEMPOL and ACh TEMPOL LN INDO increased H2O2 release over PSS; 
however, these effects failed to achieve statistical significance (p=0.085, p=0.064). Any 
solutions containing both TEMPOL and CAT had a level of H2O2 release below PSS 
(TEMPOL CAT p<0.001, ACh TEMPOL CAT LN INDO p=0.021) 
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In WKY, incubation with ACh TEMPOL caused an increase in H2O2 release from 
PSS, although this trend did not reach statistical significance (p=0.063) (Table 7C). However, 
ACh TEMPOL LN INDO did not increase H2O2 release from PSS (p=0.374) and ACh 
TEMPOL CAT LN INDO reduced H2O2 release below the levels of PSS (p=0.003). Finally, 
in contrast to SHR, TEMPOL CAT treatment was not able to lower H2O2 levels below those 
of PSS (p=0.072). 
 
VASCULAR ENZYME EXPRESSION. 
A) Anti-oxidant enzyme expression 
 Expression of the H2O2 scavenger Catalase was no different between SHR and WKY 
(WKY1.00±0.06 (n=8) vs SHR 0.93±0.08 (n=14); p=0.550) (Figure 13). Similarly, the 
antioxidant enzyme SOD-1 was no different between strains (WKY 1.00±0.10 (n=10) vs SHR 
1.05±0.09 (n=14); p=0.714) (Figure 14). Furthermore, SOD-2 expression was no different 
between strains (WKY 1.00±0.07 (n=10) vs SHR 1.06±0.05 (n=14); p=0.479) (Figure 15).  
 
B) Pro-oxidant enzyme expression 
The expression of p47phox, one cytosolic subunit of the pro-oxidant enzyme 
NAD(P)H oxidase, was similar between both strains (WKY 1.00±0.27 (n=8) vs SHR 
0.80±0.10 (n=14); p=0.592) (Figure 16). Conversely, preliminary work showed differences in 
the expression of gp91phox, one membrane bound subunit of NAD(P)H oxidase, where SHR 
expressed ~50% of WKY levels. 
 
C) Vasoactive enzyme expression 
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 eNOS expression was reduced ~44% in SHR compared to WKY (WKY 1.00±0.20 
(n=10) vs SHR 0.56±0.07 (n=14); p=0.029) (Figure 17). Conversely, COX-1 was elevated by 
~54% in SHR (WKY 1.00±0.18 (n=9) vs SHR 1.54±0.17 (n=13), p=0.045) (Figure 18). 
Preliminary work failed to detect COX-2 in the mesenteric vessels of both strains, however, 













































Values are mean±s.e.m. A: Rat tissue weights; B. Hemodynamics C. Vessel baseline 
characteristics. BM, body mass; HM, heart mass; LV, left ventricle mass; RV, right ventricle 
mass; LK, left kidney mass; HM/BM, heart mass-to-body mass ratio; LV/BM, left ventricle 
mass-to-body mass ratio RV/BM, right ventricle mass-to-body mass ratio; LK/BM, left 
kidney mass-to-body mass ratio; MAP, mean arterial pressure; SBP, systolic blood pressure; 
DBP, diastolic blood pressure; HR, heart rate; Endo fx; endothelial function test; PC, 
norepinephrine preconstriction; ACh, acetylcholine. p-value from a Student T-test for 
independent means 
A Parameter WKY n SHR n p -value 
 BM (g) 314±3 37 347±2 43 <0.001 
 HM (mg) 1372±55 24 1560±47 23 0.013 
 LV (mg) 935±31 25 1045±48 24 0.061 
 RV (mg) 224±11 23 246±11 21 0.166 
 LK (mg) 974±20 20 1108±16 21 <0.001 
 HM/BM (mg/g) 4.35±0.17 24 4.50±0.13 23 0.489 
 LV/BM (mg/g) 2.97±0.09 25 3.01±0.14 24 0.819 
 RV/BM (mg/g) 0.71±0.03 23 0.71±0.03 21 0.967 
 LK/BM (mg/g) 3.07±0.04 20 3.18±0.03 21 0.030 
B Parameter WKY n SHR n p -value 
 MAP (mmHg) 75±4 22 168±5 24 <0.001 
 SBP (mmHg) 93±4 22 198±6 24 <0.001 
 DBP (mmHg) 65±4 22 153±5 24 <0.001 
 HR (bpm) 312±9 22 418±6 24 <0.001 
C Parameter WKY n SHR n p -value 
 Normalized diameter (μm) 235±7 74 221±6 92 0.112 
 PC in Endo fx (plateau, 
mN) 
11.5±0.7 54 13.5±0.9 53 0.094 
 Endo fx -4ACh (peak, %) 79.5±2.2 54 35.0±2.3 53 <0.001 
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Table 2. Endothelium-Dependent Dilation to ACh 
 
A ACh P values 
  Strain Drug Strain*Drug 
 PC (mN) 0.071 0.010 0.716 
 MR (%) <0.001 <0.001 <0.001 
 logEC50 (mol/L) 0.079 0.133 0.998 
 AUC (AU) <0.001 <0.001 <0.001 
 
 
Values are mean±s.e.m. A: p-values from ANOVA; B. Effects of L-NAME and INDO. ACh, 
acetylcholine; PC, norepinephrine preconstriction; MR, maximal relaxation; AUC, area under 
the dose-response curve; LN, L-NAME; INDO, indomethacin; Strain, main effect of rat 







B ACh WKY SHR 
 
 
CON LN INDO LN 
INDO 
CON LN INDO LN 
INDO 
 
PC (mN) 10.9±1.0 12.0±2.7 7.0±0.8 9.1±1.4 11.0±0.9 11.4±1.5 12.5±1.2 12.1±1.4 
 
MR (%) 94.8±1.3 83.3±7.7 98.6±1.6 98.3±1.5 75.2±2.9 23.3±3.2 89.7±2.0 46.2±4.8 
 logEC50 
(mol/L) 

























D ACh WKY SHR 
  










 PC (mN) 12.8±2.2 12.3±2.0 14.6±2.0 14.1±2.4 14.4±2.3 16.6±1.5 




-9.8±0.2 -9.5±0.1 -9.7±0.0 -9.3±1.0 -9.5±0.3 -9.6±0.1 














Values are mean±s.e.m. C. Effect of CAT; D. Effect of TEMPOL. ACh, acetylcholine; PC, 
norepinephrine preconstriction; MR, maximal relaxation; AUC, area under the dose-response 
curve; LN, L-NAME; INDO, indomethacin; CAT, catalase; Strain, main effect of rat strain; 




C ACh WKY SHR 
 
 
CAT CAT LN INDO CAT CAT LN INDO 
 
PC (mN) 6.4±2.2 11.0±2.3 8.7±2.2 10.2±2.1 
 
MR (%) 99.9±3.0 91.6±2.5 75.1±7.4 29.7±3.1 
 logEC50 
(mol/L) 


















































































































































































































































































































































































































































































































































































































































































































































































































Table 3. Endothelium-Independent Dilation to SNP 
 
A SNP P values 
  Strain Drug Strain*Drug 
 PC (mN) 0.024 0.111 0.929 
 MR (%) 0.937 0.002 0.162 
 logEC50 (mol/L) 0.008 0.004 0.340 
 AUC (AU) 0.009 <0.001 0.254 
 
 
Values are mean±s.e.m. A: p-values from ANOVA; B. Effects of L-NAME and INDO. SNP, 
sodium nitroprusside; PC, norepinephrine preconstriction; MR, maximal relaxation; AUC, 
area under the dose-response curve; LN, L-NAME; INDO, indomethacin. Strain, main effect 
of rat strain; Drug, main effect of drug condition; Strain*Drug, interaction effect of rat strain 












B SNP WKY SHR 
 
 
CON LN INDO LN 
INDO 
CON LN INDO LN 
INDO 
 
PC (mN) 10.7±2.0 10.9±2.7 9.1±1.2 10.6±1.0 9.0±1.3 14.6±1.8 13.9±2.4 15.3±1.6 
 
MR (%) 93.1±2.7 89.6±2.8 94.1±1.7 96.6±0.7 92.5±1.6 94.1±1.0 97.0±1.5 96.4±0.6 
 logEC50 
(mol/L) 

























D SNP WKY SHR 
  










 PC (mN) 12.4±1.8 10.9±2.1 12.8±1.5 13.6±2.7 14.0±2.3 15.9±1.5 




-8.2±0.3 -8.3±0.1 -8.1±0.1 -8.1±0.1 -8.3±0.1 -8.6±0.2 














Values are mean±s.e.m. C. Effect of CAT; D. Effect of TEMPOL. SNP, sodium 
nitroprusside; PC, norepinephrine preconstriction; MR, maximal relaxation; AUC, area under 
the dose-response curve; LN, L-NAME; INDO, indomethacin; CAT, catalase; Strain, main 
effect of rat strain; Drug, main effect of drug condition; Strain*Drug, interaction effect of rat 




C SNP WKY SHR 
 
 
CAT CAT LN INDO CAT CAT LN INDO 
 
PC (mN) 7.8±2.0 9.2±2.3 9.6±2.1 10.3±2.1 
 
MR (%) 96.3±1.7 95.1±2.1 92.8±2.0 95.8±0.9 
 logEC50 
(mol/L) 
































































































































































































































































































































































































































































































































































































































































































































































































































Table 4. Receptor-mediated Constriction to NEPI 
 
A NEPI P values 
  Strain Drug Strain*Drug 
 MC (mN) 0.015 0.028 0.982 
 logEC50 (mol/L) 0.877 0.256 0.040 
 AUC (AU) 0.010 0.025 0.836 
 
B NEPI WKY SHR 
  
CON INDO LN INDO CON INDO LN INDO 




-7.6±0.0 -7.3±0.1 -7.3±0.2 -7.4±0.0 -7.3±0.1 -7.5±0.1 
 AUC (AU) 37.1±2.9 34.6±7.2 35.8±9.3 42.7±2.3 41.4±4.8 54.6±9.2 
 
C NEPI WKY SHR 
  














-7.5±0.2 -7.4±0.1 -7.5±0.0 -7.3±0.2 -7.6±0.1 -7.5±0.2 
 AUC (AU) 44.2±5.4 41.0±6.7 53.7±4.1 50.7±8.4 54.1±7.1 69.1±8.5 
 
Values are mean±s.e.m. A: p-values from ANOVA; B. Effects of L-NAME and INDO; C. 
Effect of CAT and TEMPOL. NEPI, norepinephrine; MC, maximal constriction; AUC, area 
under the dose-response curve; LN, L-NAME; INDO, indomethacin; CAT, catalase; Strain, 
main effect of rat strain; Drug, main effect of drug condition; Strain*Drug, interaction effect 






















































































































































































































































































































































































































































































































Table 5. Electromechanical coupling to KCl 
 
A KCl P values 
  Strain Drug Strain*Drug 
 MC (mN) 0.123 0.160 0.685 
 EC50 (mol/L) 0.845 <0.001 0.142 
 AUC (AU) 0.109 0.025 0.424 
 
B KCl WKY SHR 
  
CON INDO LN INDO CON INDO LN INDO 




46.4±0.8 49.7±2.5 40.3±1.7 49.0±1.3 44.4±2.0 39.8±0.6 
 AUC (AU) 605.4±53.1 483.8±120.0 786.0±121.2 581.5±72.5 770.8±146.8 972.3±176.2 
 
 
Values are mean±s.e.m. A: p-values from ANOVA; B. Effects of L-NAME and INDO; C. 
Effect of CAT and TEMPOL. KCl, potassium chloride; MC, maximal constriction; AUC, 
area under the dose-response curve; LN, L-NAME; INDO, indomethacin; CAT, catalase; 
Strain, main effect of rat strain; Drug, main effect of drug condition; Strain*Drug, interaction 




C KCl WKY SHR 
 
 
TEMPOL CAT LN INDO TEMPOL CAT LN INDO 
 
MC (mN) 11.3±2.5 13.1±2.2 11.7±2.8 16.9±2.7 
 EC50 
(mol/L) 
48.5±2.7 44.4±4.1 54.4±2.8 43.0±2.1 
 













































































































































































































































































































































































































































































































Table 6. Effects of Exogenous H2O2  
 
 
Values are mean±s.e.m. PC, norepinephrine preconstriction; MR, maximal relaxation; MC, 
maximal constriction; AUC, area under the dose-response curve. For H2O2 dilation, vessels 
were preconstricted with 10
-5










mol/L H2O2 was completed from a quiescent vessel. Following either the 
H2O2 dilation or H2O2 constriction dose response curves, the bath was exchanged and the 
vessels were reconstructed with 10
-5
mol/L NEPI. p-value from a Student T-test for 























 Parameter WKY SHR P value 
PC (mN) 13.9±1.3 7.5±2.6 0.059 
MR (%) 85.6±2.5 78.3±6.2 0.310 
logEC50 (mol/L) -5.6±0.1 -5.5±0.3 0.815 
H2O2 dilation  
from preconstricted 
vessel 
AUC (AU) 327.9±10.2 295.1±36.2 0.408 
MC (mN) 4.4±0.7 5.6±1.0 0.338 
logEC50 (mol/L) -3.4±0.1 -3.2±0.0 0.146 
H2O2 constriction 
from quiescent 
vessel AUC (AU) 7.0±1.5 7.9±1.1 0.759 
Post H2O2 
reconstriction 





Figure 12. H2O2-induced dilation and constriction. Values are means, n per group in 
parenthesis. NEPI, norepinephrine; Dilation, relaxation from NEPI preconstriction; 
Constriction, developed tension from quiescent vessel expressed relative to NEPI 
preconstriction from endothelial function test. Symbols for statistical difference, and error 




























Values are mean±s.e.m, n=5-8 per group. A: Comparison of control responses with L-NAME 
and INDO; B: Effect of CAT C: Effect of TEMPOL. Basal, vessels not stimulated by ACh; 
Stimulated, vessels treated with ACh; LN, L-NAME; INDO, indomethacin; CAT, catalase. 










 WKY SHR 
 
 
Basal Stimulated Basal Stimulated 
 
 
PSS LN INDO ACh ACh 
LN INDO 






17.9±2.7 21.6±4.8 15.2±2.6 11.8±2.8 20.4±3.3 17.3±5.1 18.0±2.7 20.6±4.2 
B 
 WKY SHR 
 
 
Basal Stimulated Basal Stimulated 
 
 
CAT CAT LN 
INDO  
ACh CAT ACh CAT 
LN INDO  
CAT CAT LN 
INDO  
ACh CAT ACh CAT 





5.8±2.4 0.4±0.4 9.5±5.6 7.9±4.0 1.0±0.8 1.5±0.5 5.1±2.3 0.5±0.5 
C 
 WKY SHR 
 
 













































Figure 13. Protein levels of catalase. Values are means±s.e.m, n = 10-12 per strain. Top: 
representative immunoblots Bottom: Expression differences between rat strains. Please refer 























Figure 14. Protein levels of SOD-1. Values are means±s.e.m, n = 10-14 per strain. Top: 
representative immunoblots Bottom: Expression differences between rat strains. Please refer 




























Figure 15. Protein levels of SOD-2. Values are means±s.e.m., n = 10-14 per strain. Top: 
representative immunoblots Bottom: Expression differences between rat strains. Please refer 



























Figure 16. Protein levels of p47phox. Values are means±s.e.m., n = 8-14 per strain. Top: 
representative immunoblots Bottom: Expression differences between rat strains. Please refer 
























Figure 17. Protein levels of eNOS. Values are means±s.e.m., n = 10-14 per strain. Top: 
representative immunoblots Bottom: Expression differences between rat strains. Please refer 






















Figure 18. Protein levels of COX-1. Values are means±s.e.m., n = 9-13 per strain. Top: 
representative immunoblots Bottom: Expression differences between rat strains. Please refer 


















 The aim of this study was to investigate the role of endogenous H2O2 in 3NP-mediated 
endothelium-dependent dilation of rat mesenteric resistance arteries, and the changes that 
occur in these vessels with essential hypertension. The main findings of this study are:  
 
1. SHR rats exhibit severe hypertension that coincides with impaired endothelium-
dependent dilation and COX products mediate the impaired vasomotor function.  
2. When NO and PG are inhibited, H2O2 is an endogenous endothelium-mediated dilator 
in both WKY and SHR while exogenous H2O2 can both dilate and constrict mesenteric 
vessels. 
3. The proportion of ACh-induced dilation that is mediated by 3NP is reduced in SHR 
compared to WKY mesenteric arteries.  
4. SHR and WKY mesenteric vessels express similar levels of both anti- and pro-oxidant 
enzymes; however, SHR expresses elevated COX-1 and reduced eNOS.  





A) Comparison of control responses 
As expected, SHR rats had an elevated blood pressure compared to WKY, and their 
mesenteric arteries demonstrated an impaired endothelium-dependent dilation to ACh. SHR 
mesenteric arteries achieved only ~79% of the maximal relaxation and total response in the 
ACh dose-response curve, and less than 50% of the dilation in the endothelial function test 
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compared to age-matched WKY (Figure 2). Notably, the maximal response to SNP was no 
different between SHR and WKY when collapsed across drug condition but SHR had a ~6% 
greater AUC and an 85% increase in sensitivity to SNP compared to WKY. This increased 
AUC and sensitivity in the SHR was not conserved in the comparison of the CON responses, 
suggesting that, when collapsed across drug conditions, there were other strain-dependent 
differences revealed by the drug treatments that increased the responses SHR arteries over 
WKY. The similarity in SNP responses in both WKY and SHR CON groups suggest that the 
reduced dilation to ACh in the SHR is due to impaired endothelial vasomotor function, and 
not due to impaired responses of the VSM to NO, a finding that is in agreement with previous 
works in the SHR mesenteric arteries (Diederich et al, 1990; Jameson et al, 1993). However, 
the similarity in responses to SNP does not rule out the possibility that the sensitivity of the 
VSM to 3NP-mediated dilators may be different between SHR and WKY, as 3NP-mediated 
dilation may employ mechanisms distinct from the PKG/sGC/cGMP pathway, such as H2O2-
induced hyperpolarization, to relax the VSM (Lucchesi et al, 2005; McGuire et al, 2001). 
Further investigations with a K-channel activator to induce hyperpolarization at the VSM may 
have revealed strain dependent differences in the VSM sensitivity to 3NP dilators (Lucchesi et 
al, 2005; McGuire et al, 2001). However, in the present study, treatments with LN, INDO and 
CAT were capable of demonstrating the contributions of NO, PGs, and endogenous H2O2 to 
endothelium-dependent dilation, and exposed the pathways responsible for vasomotor 





 B) Effect of LN on ACh- and SNP-induced dilation 
Incubation with 300μmol/L LN inhibited maximal dilation to ACh by ~69% in SHR 
mesenteric arteries but only caused a ~12% inhibition in WKY, suggesting that the 
hypertensive vessels may have a greater dependency of NO for endothelium-dependent 
dilation despite a reduced total endothelium-dependent dilation (Figure 2). Previous work 
supports an increased role for NO in the mesenteric vasculature of SHR over WKY, revealed 
by differences between LN INDO and INDO alone drug treatments. LN, in the presence of 
INDO, inhibited ACh-induced dilation of WKY mesenteric arteries compared to incubation 
with INDO alone, but only at the lowest concentrations of ACh (10
-7.5
mol/L) (Li and Bukoski, 
1993). Conversely, in SHR, administration of LN and INDO reduced the ACh response by 
more than 90% from INDO treated vessels. The administration of methylene blue, an inhibitor 
of sGC strengthened these findings, where SHR dilation decreased ~80% while WKY 
responses were unchanged. Shimokawa et al (1996) provided further support for the present 
findings, reporting that WKY arteries become proportionally less reliant on NO, and more 
reliant on 3NP in response to ACh as the vessel size decreases, an effect that coincides with 
reduced eNOS expression in smaller vessels, and a reduced eNOS content per endothelial cell 
in coronary resistance arteries (Laughlin et al, 2003). This previous work, together with the 
present study, supports the decreased role of NO as a dilator in WKY and suggests that NO 
may be proportionally more important for dilation in the SHR mesenteric vessels. 
Consistent with the SNP responses of WKY and SHR arteries under CON conditions, 
the SNP responses following LN treatment were similar between strains (Figure 5), 
suggesting that the effect of LN on ACh-induced dilation in this preparation was endothelium-
dependent and not likely related to increased VSM sensitivity for NO. This finding is 
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supported by previous studies where sGC expression is similar in the mesenteric arteries of 
20wk old SHR and WKY (Ndisang et al, 2002), suggesting that the sensitivity of the VSM to 
NO is not altered. In contrast, other work has demonstrated an increased sensitivity and 
maximal dilation to SNP in the mesenteric arteries of 4wk old SHR and 35wks old SHRSP 
compared to age-matched WKY (Jameson et al, 1993; Diederich et al, 1990). However, the 
latter studies used SHR rats that were younger with a lower SBP (120mmHg; Jameson et al, 
1993) and older with a higher SBP (210mmHg; Diederich et al, 1990) than the 16-20wks old 
rats in the present study (SBP: 198mmHg), suggesting an age and hypertension related 
difference in the sensitivity of SHR for SNP compared to age-matched WKY. In addition, the 
4wk old SHR did not have the elevated dependence on NO for ACh-induced dilation found in 
the present study (Jameson et al, 1993), suggesting that the improvement in VSM sensitivity 
to NO in SHR may be a compensatory adaptation at 4wks, which is no longer necessary at 16-
20wks as NO bioavailability may be increased in the endothelial layer. 
eNOS expression was reduced by ~44% in the SHR mesenteric arteries compared to 
WKY, which seems to contrast with the increased LN-sensitive component in the ACh 
response of SHR; however, preliminary work suggests that eNOS may have been post-
translationally activated to provide the increased NO for dilation in the SHR. Preliminary 
western blots from SHR and WKY mesenteric arteries indicated that the expression of the 
phosphorylated eNOS protein (phospho-eNOS) was similar between strains (data not shown). 
The reduced eNOS expression in the SHR coupled with the consistent level of phopsho-eNOS 
suggests that the phospho-eNOS:eNOS ratio, an indicator of eNOS activation, was elevated. 
Since phosphorylation of eNOS at Ser
1179
 increases both basal and stimulated NO production 
(Boo et al, 2003), the potential increase in the phospho-eNOS:eNOS ratio in the SHR 
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mesenteric vessels may have allowed for the increased provision of NO in the SHR. In 
addition, the lack of differences in the expression of the pro-oxidant enzyme p47phox, and 
antioxidant enzymes SOD-1, SOD-2, and CAT in the SHR and WKY mesenteric arteries may 
indicate that ROS stress did not contribute to increased NO scavenging in these vessels, as 
increased pro-oxidant and decreased anti-oxidant enzymes in the SHR aorta are often 
associated with increased oxidative stress and reduced NO bioavailability (Graham and Rush, 
2004). Thus, the increased NO component of endothelium-dependent dilation in the SHR may 
be related to increased post-translational phosphorylation of eNOS and a level of oxidative 
stress that could have been managed by the endogenous antioxidant enzymes. 
 
C) Effect of INDO on ACh- and SNP-induced dilation  
Treatment with INDO improved the AUC of the ACh response by 23% in SHR, 
achieving the same level as WKY CON, and despite an increase maximal dilation in SHR, 
maximal dilation remained higher in WKY CON compared to SHR INDO (Figure 2). In 
WKY, AUC was augmented by 12% with INDO over CON; however, INDO did not improve 
the maximal response in the WKY (Figure 2). The present findings suggest that constrictory 
PGs may be responsible for the impaired endothelium-dependent dilation in the SHR 
mesenteric arteries, and contribute to reduced dilation at submaximal, but not maximal doses 
of ACh in the WKY. This result is in agreement with early work where INDO improved ACh-
induced peak relaxation in mesenteric arteries of 4-34wks old SHR but not in age matched 
WKY (Luscher et al, 1990; Jameson et al, 1993; Diederich et al, 1990). ACh-induced 




mol/L) in renal arteries 
of 24wks old WKY (Luscher et al, 1988), supporting the involvement of constrictory PGs. 
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The improvement with INDO at high doses of ACh in WKY renal arteries (Luscher et al, 
1988), but not in the WKY mesenteric arteries in the present study, may be due to differences 
in the maximal dilation to ACh. In contrast to the 95% dilation in WKY CON, the renal 
arteries dilated only ~70% allowing for improvements in maximal dilation in the latter. 
Consistent with Diederich et al (1990), INDO did not alter the AUC or maximal 
response to SNP in the mesenteric arteries of either SHR or WKY, suggesting that the 
improvements in ACh-induced dilation by INDO treatment is not due to changes in the 
dilatory response of the VSM to NO. Since the use of SNP would not reveal differences in the 
sensitivity of the VSM for PGs, due to the separate molecular pathways that control PG and 
NO-induced dilation in the VSM, the large improvement in ACh-induced dilation in the SHR 
could still be a consequence of greater sensitivity of the VSM to constrictory PGs in SHR.  
Previous work has demonstrated that the responses of mesenteric arteries to the TXA2 
analogue U-46619 is no different between 12wk old SHR and WKY (Lang et al, 1995), 
suggesting that the sensitivity of the VSM for TXA2, one of the constrictory PGs, is not 
altered with hypertension; however, the SHR aorta does exhibit greater sensitivity to PGF2  
(Ge et al, 1995). Together, these findings suggest that the improvement in the response to 
INDO in the present study was likely due to reduced release of constrictory PGs from the 
endothelium following ACh stimulation, but the SHR arteries may also have increased 
sensitivity to some, but not all, constrictory PGs. 
The importance of COX-1 to vasomotor dysfunction in the SHR mesenteric arteries is 
supported by the 54% increase in COX-1 expression over WKY. Preliminary work did not 
detect COX-2 in the mesenteric arteries of SHR or WKY (although COX-2 was highly 
expressed in the SHR thoracic aorta standard -- data not shown), suggesting that the 
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dysfunction in endothelium-dependent dilation in the SHR is mediated by a metabolite of 
COX-1. In support of the COX-1 expression data from the present study, Ge et al (1995) 
detected a ~2-fold greater expression of COX-1 mRNA and protein in the aorta of SHR 
compared to WKY. In the quiescent aortas of 35wks old SHR, ACh invokes a potent 
constriction that is inhibited with removal of the endothelium and with exposure COX-1 
specific inhibitor tenidap, but not the COX-2 specific inhibitor NS-938 (Ge et al, 1995). ACh 
also causes an increased release of the constrictory PGH2 and PGF2  from the SHR aorta 
compared to WKY, an effect that was sensitive to INDO. The direct provision of PGF2  to 
denuded SHR aorta caused increased constriction compared to WKY, while PGH2 caused 
comparable constriction between strains, suggesting that the aortic VSM in SHR has altered 
sensitivity to PGF2 . A similar effect is noted in the murine mesenteric arteries in the 
angiotensin-II (AII) model of induced hypertension, where treatment of the arteries with a 
COX-1 inhibitor or a thromboxane-prostanoid receptor antagonist SQ-29548, but not a COX-
2 or a thromboxane sythetase inhibitor ozagrel, improves vasodilation to ACh in the AII-
treated mice but not in controls (Virdis et al, 2007). Furthermore, AII-treatment increased 
COX-1 and decreased COX-2 mRNA and protein expression in the mesenteric arteries 
(Virdis et al, 2007), confirming a role for COX-1 in the vasomotor dysfunction associated 
with hypertension. However, the pivotal role of the TP receptor outlined by Viridis et al 
(2007) is not consistent with results in SHR mesenteric arteries since pretreatment with the 
thromboxane-prostanoid receptor antagonist SQ-29548, or the thromboxane synthetase 
inhibitor CGS-13080, failed to improve ACh-induced dilation (Jameson et al, 1993, Diederich 
et al, 1990). Taking these findings into account, it is possible to speculate that, in the present 
study, the reversal of the impaired ACh-mediated dilation in the SHR mesentery by INDO 
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treatment may have been due to an increased expression of COX-1, leading to the increased 
release of PGs, and a possible increase in sensitivity to PGF2 ; however, the involvement of 
the TP receptor in this response remains unclear. 
 
D) Effect of L-NAME and INDO on ACh- and SNP-induced dilation  
Co-incubation with LN and INDO revealed the 3NP component of ACh-induced 
dilation in the mesenteric arteries of SHR and WKY (Figure 2). In WKY, the 3NP component 
accounted for the entire CON response, but was only responsible for 61% of the SHR 
response, suggesting a lower proportion of SHR dilation is mediated by 3NP compared to 
WKY. The proportion of 3NP involvement in ACh-induced dilation in the present study is 
supported by the literature, since, when NO and PG are inhibited, normotensive SD 
mesenteric arteries dilate 95% (Chauhan et al, 2003) and 15wk old WKY femoral arteries 
dilate 70%, while SHR femoral arteries dilate only 50% to endothelium-dependent agonists 
(Mori et al, 2006). The comparison of the 3NP contribution between strains in the present 
study indicates that SHR do not compensate for impaired vasomotor function by augmenting 
the 3NP proportion of their endothelium-dependent dilation, relying instead on an increased 
level of NO for dilation. Indeed, Feletou and Vanhoutte (2006) state that NO levels are 
generally maintained in mesenteric arteries but the 3NP-component is impaired in 
hypertension.  
Co-incubation with LN and INDO increased the maximal response to SNP by 4% in 
both SHR and WKY (Figure 5-6), suggesting that endothelium-derived factors may modulate 
the response of mesenteric arteries to SNP. This finding is supported by other work where the 
SNP response in endothelium-denuded mesenteric arteries of SHRSP and WKY are no 
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different, while the responses of endothelium-intact SHRSP arteries are greater than WKY 
(Diederich et al, 1990). These results in the endothelium-intact vessels contrast with the 
similarity in SHR and WKY CON responses to SNP found in the present study; however, this 
difference may be explained by the much older rats used in the aforementioned study.  
As the ACh responses integrate the release of factors from the endothelium with the 
sensitivity of the smooth muscle for those factors, it is possible that the increase in SNP 
responses following LN INDO treatment would exaggerate the apparent contribution of 3NP 
components to the ACh response. The implication of the improved SNP response with LN 
INDO could also magnify the component of endothelium-dependent dilation mediated by 
H2O2, which may operate through the same sGC/cGMP/PKG mechanism stimulated by SNP 
(Cohen, 2000; Itoh et al, 2003; Leung et al, 2006). However, endogenous H2O2 may also 
dilate through mechanisms unrelated to the SNP response, including direct or indirect 
hyperpolarization of the VSM (Hattori et al, 2003; Lucchesi et al, 2005). Taking these 
findings into consideration along with the results of the present study, the apparent 
contribution of the 3NP pathway to endothelium-dependent dilation, and the role of 
endogenous H2O2 in this pathway, may be exaggerated in the mesenteric arteries of SHR and 
WKY by increased sensitivity of the VSM to NO in 3NP conditions, assuming that H2O2 
operates through a similar pathway to SNP. The influence of H2O2 on mechanisms separate 
from sGC/cGMP/PKG at the VSM could not be assessed by SNP, suggesting that the addition 
of a hyperpolarization dose-response curve would be important to further test the sensitivity 
of the VSM for mechanisms employed by endogenous H2O2. Nevertheless, the similar 
improvements in SNP responses following LN INDO between strains suggest that changes in 
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the endothelium cause differences in the contribution of 3NP between strains, although 3NP 
may operate through different pathways at the VSM that were not investigated. 
 
E) Effect of CAT on 3NP-mediated dilation  
A major finding of this study is the greater influence of endogenous H2O2 on 
endothelium-dependent dilation in SHR mesenteric arteries over WKY. This finding is based 
on the observation that incubation with CAT LN INDO caused a 36% decrease in maximal 
dilation from LN INDO in SHR but only a 7% decrease in WKY. It should be noted that the 
large decrease in dilation in the SHR reached significance in the Student T-test (p=0.041) but 
not in the ANOVA (p=0.062). These differences in statistics are likely attributable to the 
variance in the responses of groups unrelated to SHR LN INDO or CAT LN INDO that were 
included in the ANOVA model. These data show that endogenous H2O2 may contribute up to 
22% of maximal dilation in SHR but only 3% of maximal dilation in WKY, suggesting that 
H2O2 may be a greater mediator of endothelium-dependent dilation in SHR when LN and 
INDO are present.  
Since CAT only inhibited ACh-induced dilation in combined incubations with LN and 
INDO, it seems that endogenous H2O2 is vasoactive when NO and PG are inhibited. In 
support of this finding, incubation with CAT alone or a CAT and INDO co-incubation did not 
alter ACh-induced dilation in mouse mesenteric arteries (Matoba et al, 2000). In addition, this 
effect is likely attributable to alterations in the endothelial layer since all preconstrictions, and 
the KCl, NEPI, and SNP responses, were similar between the CAT LN INDO and LN INDO 
conditions. The finding that H2O2 acts as an endogenous vasodilator through a 3NP pathway 
is supported by studies in mouse mesenteric arteries (Matoba et al, 2000; Morikawa et al, 
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2003), pig and dog coronary arteries (Matoba et al, 2003; Yada et al, 2003) where CAT, in 
the presence of LN and INDO inhibited ACh- or BKY-induced dilation. Contrary to the 
present study, in diseased human coronary arterioles, CAT alone has been shown to reduce 
dilation to flow (Miura et al, 2003). Importantly, in Miura et al (2003), all experiments were 
performed without the addition of NOS or COX inhibitors and normal dilatory responses of 
the vessels were not established, so it is possible that NO and PG were inhibited 
pathophysiologically thereby exhibiting an inhibitory effect of CAT in the absence of LN and 
INDO. Nevertheless, other work in mouse mesenteric arteries (Ellis et al, 2003), mouse aorta 
(Suvorava et al, 2005), human radial arteries (Hamilton et al, 2001), and WKY coronary 
arteries (Fulton et al, 1997) suggest that H2O2 is not involved in the 3NP component of 
endothelium-dependent dilation. The present study does not rectify these divergent findings, 
as differences in species, vessel bed, endothelium-dependent agonist, and method to quantify 
vasomotor function have not been addressed. However, this study is the first to demonstrate 
that H2O2 acts as an endogenous vasodilator in the mesenteric arteries of both rat strains, but 
to a greater extent in SHR.  
Treatment with CAT alone did not alter the ACh or SNP responses from CON in 
either strain; however, pre-incubation with CAT alone reduced NEPI preconstriction by 41% 
in WKY and 21% in SHR. This reduction in preconstriction could have hidden an impairment 
in ACh dilation responses with CAT alone, as a lower preconstriction would have 
exaggerated the relative % dilation for the same absolute change in tension, assuming that 
ACh responses are unaffected by the magnitude of the preconstriction. However, previous 
work in SHR and WKY aorta, which also demonstrated different preconstrictions to PE, show 
a similar interpretation in ACh data when expressed either as % dilation or as change in 
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absolute tension (Graham and Rush, 2004). This previous work suggests that despite the 
differences in preconstriction, CAT likely did not affect ACh dilation either expressed relative 
to NEPI, or as change in absolute tension. Additionally, if the loss in tension with ACh was 
proportional to, rather than independent of preconstricted tension, the effect of CAT would 
not be altered from the present results since the ACh responses were expressed relative to the 
preconstricted tension. Importantly, the calculations of the 3NP component of ACh-induced 
dilation were not affected by the method of expressing the data, as NEPI preconstriction was 
consistent between LN INDO and CAT LN INDO conditions.  
One potential relationship revealed by the present study is the association between 
COX-1 and the role of H2O2 as a 3NP-mediated dilator in the SHR. In the SHR response to 
ACh, LN reduced maximal dilation to 23%, which was increased to 46% with LN INDO, and 
subsequently reduced to 30% with CAT LN INDO (Figure 3). This relationship was 
conserved in WKY, but the magnitude of the effects were reduced, where LN reduced dilation 
to 83% of maximum, LN INDO increased dilation to 98%, and CAT LN INDO reduced 
maximal dilation to 92%. Statistically, LN and CAT LN INDO maximal dilation responses 
were no different, but LN INDO was greater than both LN and CAT LN INDO; a relationship 
that was consistent between strains. This relationship suggests that COX inhibition may allow 
H2O2 to become available for dilation, an effect that is sensitive to CAT, and is greater in 
SHR than WKY. This association is reinforced by the greater role of COX-1 in the SHR than 
WKY, indicated by the larger improvement in AUC following INDO treatment in SHR, and 
the overexpression of COX-1 in SHR mesenteric arteries. The apparent relationship between 
COX-1 and H2O2 is not revealed in the responses to SNP, NEPI, or KCl, suggesting that this 
effect is not occurring through modulation of the VSM. 
 80 
In support of the relationship between COX and H2O2 availability, H2O2 is required 
for activation of the COX in purified enzyme preparations (Davidge, 2001). This interaction is 
illustrated by the inhibition COX-1 and COX-2 activity in the presence of the H2O2 scavenger 
GPx (Mashall et al, 1987; Kulmacz and Wang, 1995) and with increased activation of the 
COX enzymes with greater doses of ethyl hydrogen peroxide or a fatty acid hydroperoxide 
(Lu et al, 1999).  In addition, COX enzymes are known peroxidases that consume H2O2 in the 
conversion of PGG2 to PGH2 in purified cell extracts (Lu et al, 1999; Liu et al, 2007). 
Interestingly, COX-1 metabolism is inactivated at lower doses of GPx than COX-2, 
suggesting that COX-1 requires almost 10-fold more H2O2 to become activated compared to 
COX-2 (Kulmacz and Wang, 1995). In light of the different levels of H2O2 required for 
activation of COX-1 and COX-2, this mechanism may allow for regulation of PG production, 
especially considering the ease of movement of H2O2 across cell membranes (Kulmacz and 
Wang, 1995; Antunes and Cadenas, 2000). In support of the relationship of H2O2 and COX in 
vascular cells, bovine aortic VSM cells induced with COX-2 and stimulated by endotoxin, 
H2O2, and the NO donor SIN-1 increase PG synthesis (Schildknecht et al, 2005). Futhermore, 
LN, SOD, and the NADPH oxidase inhibitor apocynin each caused dose-dependent decreases 
in PG production from these same cells, suggesting that while H2O2 can directly stimulate PG 
production in VSM cells, ONOO
-
 may also be involved (Schildknecht et al, 2005). In 
addition, in perfused porcine coronary arteries, arachidonic acid (AA)-induced dilation is 
inhibited by INDO, by PEG-CAT, and by PEG-SOD, suggesting that ROS mediate the 
metabolism of COX to produce dilatory PGs (Oltman et al, 2003). Importantly, AA alone 
increased ROS formation in coronary vessels, an effect that is inhibited by pretreatment of the 
vessels with PEG-SOD and PEG-CAT co-incubation, or with INDO alone (Oltman et al, 
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2003). Together, the findings of Oltman et al (2003) suggest that ROS are required for COX 
to metabolize AA and cause dilation but AA metabolism by COX can also stimulate the 
release of ROS in intact vessels. The above study also implies that ROS do not become more 
bioavailable when INDO is present, seemingly refuting the theory proposed by the present 
study. However, the direct provision of AA was used to stimulate endothelium-dependent 
dilation through COX, whereas the present study administered ACh to augment intracellular 
Ca
2+
 to increase AA liberation for COX metabolism. The differences in the agonists, as well 
as a difference in species, vessel bed, and level of hypertension may allow for INDO to 
increase H2O2 bioavailability, possibly through inhibition of COX-1 peroxidase activity, but 
further investigation is required to confirm this theory.  
 
F) Direct actions of exogenous H2O2 on vasomotor function  
Further evidence supports a role for H2O2 as an endogenous vasodilator. Following 




mol/L in WKY and SHR 
mesenteric arteries (Figure 12). In addition, pilot work in SD mesenteric vessels indicated that 





becomes less dependent on the endothelium thereafter (Figure 21). In the H2O2 dilation curve, 
SD E- vessels experienced a 40% decrease in AUC from E+; however, the VSM was still 
capable of dilating to higher concentrations of H2O2, possibly due to irreversible cellular 
damage (Gil-Longo and Gonzalez-Vazquez, 2005). The H2O2 dilation data in all strains, taken 
together with the ACh responses in the WKY and SHR suggest that endogenous H2O2 may 
act at the endothelium to either directly or indirectly cause dilation at the vascular smooth 
muscle. Since the endothelium potentiated the dilatory response of the VSM to exogenous 
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H2O2 in SD, it is possible that endogenous H2O2 may act at the endothelium to release a 
second messenger distinct from H2O2 to cause relaxation at the VSM. However, at higher 
concentrations, exogenous H2O2 can directly relax the VSM, possibly through irreversible 
cellular damage.  
In both the SHR and the WKY, the H2O2 dilation curve developed a reconstriction 




mol/L. Interestingly, the H2O2 





~35-45% of NEPI preconstriction values (Figure 12). These data suggest that H2O2 causes a 
constriction at mmol/L concentrations that is not dependent upon the level of baseline tone. In 
addition, both SD E+ and E- mesenteric arteries constricted to approximately the same tension 
(Figure 21), suggesting that the H2O2 induced constriction was endothelium-independent. 
 In response to exogenous H2O2, previous studies have shown that dilation occurs 
through the stimulation of COX metabolites leading to hyperpolarization of the VSM, 
reinforcing the theory that H2O2 is required for COX activity in the mesenteric arteries of 
SHR. Endothelium-intact and -denuded internal thoracic arteries from patients undergoing 
coronary artery bypass graft show a dose-dependent relaxation to H2O2 that is inhibited by 
~50% with INDO, and by ~90% with the voltage gated K
+
-channel blocker 4-aminopyridine 
(Nacitarhan et al, 2007). In addition, evidence from rabbit mesenteric VSM demonstrates a 
reduction of H2O2-induced hyperpolarization that is additive with COX and 5-LOX inhibition, 
suggesting that these lipids may lead to the hyperpolarization and subsequent relaxation of 
VSM to H2O2 (Hattori et al, 2003). However, COX activation and hyperpolarization of the 
VSM may independently cause dilation in response to H2O2 administration. INDO and COX-
1 specific inhibition in intact pig coronary arterioles provides the same reduction in H2O2 
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dilation as denudation, likely through inhibition of PGE2, although PGE2-mediated dilation 
was not sensitive to blockade of KCa-channels (Thengchaisri and Kuo, 2003). Similarly, 
preconstriction of mouse aorta with KCl eliminates dilation to 10
-4
mol/L H2O2, but the vessel 
still exhibits an endothelium-independent dilation of nearly 80% at 10
-3.5
mol/L H2O2, an 
effect that is not altered by incubation with INDO (Gil-Longo and Gonzalez-Vazquez, 2005). 
Together these studies suggest that H2O2 could cause dilation either through direct 
hyperpolarization of the vascular smooth muscle, or through the provision of PGs to dilate the 
VSM, independent of hyperpolarization. This body of evidence supports a role for H2O2 in the 
production of vasoactive PG by COX in the mesenteric arteries of the present study, and 
allows for the possibility that INDO may inhibit COX-1 allowing H2O2 to become 
bioavailable for dilation. 
Reconstriction with NEPI in both SHR and WKY mesenteric arteries was completely 
abolished following both the H2O2 constriction or dilation curves, suggesting that the 
constrictory mechanisms of the arteries were irreversibly damaged by the previous exposure 
to H2O2. This finding is supported by studies in denuded mesenteric arteries of SHR and 
WKY where repeated 30min administrations of 5x10
-4
mol/L H2O2 caused an apparent 
tachyphylaxis in response to subsequent bolus injections of H2O2 that is consistent between 
strains (Gao and Lee, 2001). Similarly, exposure of WKY aorta to 3x10
-4
mol/L H2O2 for 1hr, 
followed by a 1-2hr washout eliminates constriction to PE and KCl (Gil-Longo and González-
Vázquez, 2005) suggesting that the tachyphylaxis noted in the Gao and Lee (2001) study may 
have been due to damage of the constrictory mechanism rather than sensitization to the H2O2 
stimulus. Consistent with these findings, and the present study, the loss of contractile function 




mol/L, leading to oxidative stress-induced cell death (Stone and Yang, 2006; 
Antunes and Cadenas, 2001). Curiously, in the present study, both WKY and SHR mesenteric 
vessels were still capable of constricting at the maximal dose of 10
-2
mol/L H2O2; however, 
they were not able to constrict in the subsequent NEPI administration after 15min incubation 
in PSS. This observation suggests that the effects of high doses of H2O2 may not be 
immediate, but may stimulate a cascade of events leading to damage of the VSM contractile 
mechanisms.   
The theory that endogenous H2O2 acts as a vasodilator in our preparation is largely 
dependent upon the effect of CAT on dilation in the presence of LN and INDO. As a result, 
the efficacy of the scavenging of H2O2 with CAT was determined using vascular myography 
and in measures of H2O2 accumulation by Amplex Red. Pre-incubation of both E+ and E- SD 
mesenteric arteries with 860U/mL CAT showed a 55-74% reduction in AUC of the H2O2 
dilation curve that was not affected by the absence of the endothelium (Figure 21). In 
addition, administration of CAT alone, or in the presence of ACh, LN, INDO, or TEMPOL 
caused a reduction in H2O2 accumulation, measured by the extracellular dye Amplex Red in 
suspensions of the mesenteric vessels of both SHR and WKY. Taken together, these data 
support the theory that the 860U/mL CAT, in the conditions employed, was capable of 
scavenging the H2O2 released endogenously to cause dilation in the mesenteric arteries of 
SHR and WKY. In addition, the absence of a change in ACh- or SNP-induced dilation in the 
presence of CAT alone suggests that the enzyme did not injure the vessel, or cause a loss of 
tension unrelated to the level of H2O2. The efficacy of CAT is supported by previous studies 
in mouse mesenteric arteries where CAT, along with LN and INDO, greatly inhibited 3NP-
mediated dilation to ACh, an effect that was prevented with the inactivation of CAT with AT 
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(Matoba et al, 2000). In addition, BKY-induced hyperpolarization of porcine coronary 
microvessels is inhibited by CAT alone and the inactivation of CAT with AT reverses this 
effect suggesting that CAT is not damaging the ability of the arteries to hyperpolarize 
(Matoba et al, 2003), confirming that the reduction of ACh-induced dilation with CAT is 
likely due to scavenging of H2O2, not vessel damage. Therefore, CAT decreased H2O2-
induced dilation, decreased H2O2 accumulation, and decreased the 3NP component of ACh-
induced dilation, effects that were likely caused by the peroxidase activity of CAT. 
  
VASOCONSTRICTION 
 A) Comparison of control responses 
 The SHR maximal response to the receptor-mediated agonist NEPI was increased by 
25% over WKY when collapsed across drug conditions, and SHR CON had a 24% increase in 
NEPI constriction over WKY CON (Figure 8). This finding coincides with a 25% increase in 
SHR preconstriction to NEPI prior to the SNP dose-response curve, when collapsed across 
drug conditions. Interestingly, no effect of strain was noted for KCl responses when collapsed 
across drug condition, or when compared between CON groups (Figure 10). Taken together, 
these constriction results suggest that the increased responses in SHR compared to WKY may 
be due to increased expression, activity, or sensitivity of the 1-adrenergic receptor ( 1-AR), 
rather than differences in the capacity of the VSM to constrict to electrochemical stimuli. The 
increased 1-AR-mediated responses in SHR seemingly contrasts with several studies where, 
in response to NEPI, and in the absence of PRO, constriction in mesenteric vessels is no 
different between 4wk old WKY and SHR (Jameson et al, 1993) or between 35wk old WKY 
and SHRSP (Diederich et al, 1990). However, in the presence of PRO and cocaine, the 
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mesenteric arteries of 25wks old SHR show a 10% greater maximal NEPI constriction 
compared to WKY (Yang et al, 2005), which supports the findings of the present study. NEPI 
re-uptake likely did not account for differences between SHR and WKY mesenteric arteries in 
the present studies as NEPI constriction of SHR and WKY femoral arteries is not altered by 
the presence of cocaine (Mulvany et al, 1982) In support of the present study, SHR generate 
50-70% greater pressure to a maximal dose of the selective 1-AR receptor agonists 
methoxamine and phenylephrine (PE), compared to age-matched WKY (Husken et al, 1994; 
Girouard and Champlain, 2005). Furthermore, the 1-AR has greater affinity for NEPI in the 
mesenteric arteries of SHR compared to WKY (Nyborg and Bevan; 1988). Thus, the results 
of the present study, together with the literature, suggest SHR mesenteric arteries have 
augmented responses to 1-AR stimulation, an effect that may be due to increased sensitivity 
of the 1-AR for NEPI in SHR. 
In contrast to the NEPI results, the KCl responses were no different between SHR and 
WKY CON groups (Figure 10). These findings are supported by work using a similar method 
of isolated vessel myography where mesenteric arteries of 12wk SHR had a similar 
constriction to 100mmol/L KCl as age-matched WKY (Lang et al, 1995). Similarly, the aortas 
of 15-16wk old SHR and WKY have a similar constriction to 60mmol/L KCl (Graham and 
Rush, 2004). In perfused mesenteric arterial beds, the responses of 15wk old SHR and WKY 
to KCl are also similar (Girouard and Champlain, 2005). However, several findings contrast 
with the findings of the present study by demonstrating an increase in KCl constriction in 
SHR over WKY. SHR mesenteric arterial beds produce greater peak perfusion pressure at 
100mmol/L KCl compared to WKY (Le Marquer-Domagala and Finet, 1997); however, the 
SBP of the SHR in this study were markedly lower than in the present study (146 vs. 
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198mmHg). Indeed, the MAP of the SHR in the Girouard and Champlain (2005) study, where 
KCl responses were no different between strains, was 152mmHg, and approximates the MAP 
of 168mmHg in the present study, suggesting that the differences in KCl constriction may be 
blunted as blood pressure increases in SHR. Dickhout and Lee (1997) demonstrated a greater 
peak and total response to KCl in the perfused mesenteric arteries of SHR rats at 4wks of age 
compared to age-matched WKY whereas at 74wk SHR mesenteric arteries had a reduced KCl 
constriction compared to age-matched WKY and 12wk SHR (Lang et al, 1995). Together 
with the findings of the present study, these results suggest that the KCl responses in SHR 
may be increased in youth, equivalent in adulthood, and reduced in senescence. Nevertheless, 
other work indicates that the response to direct VGCC stimulation by Bay k 8644 is 
augmented in 12wk SHR compared to WKY, and harvested myocytes from these vessels 
demonstrate a greater increase in Ca
2+
 current in SHR than WKY, a difference that was 
maintained with additional stimulation by Bay k 8644 (Matsuda et al, 1997). Differences in 
VGCC function likely exist between SHR and WKY; however, the vascular responses to 
depolarization by high K
+
 in the present study may involve the non-specific activation of ion 
channels on the membrane and intracellular systems that could affect the function of the 
VGCC in a complex interaction, and could obscure differences in specific VGCC function 
between SHR and WKY.  
 
 B) Effect of LN and INDO on constriction 
 In response to INDO incubation, NEPI and KCl responses were no different from 
CON when collapsed across strain, suggesting that PGs do not alter either 1-AR-mediated or 
electromechanical contraction in mesenteric arteries. In contrast to the present study, INDO 
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treatment alone has been shown to reduce NEPI-induced constriction in 30-34wk SHR 
mesenteric vessels but not WKY, an effect that implies the impairment of dilatory PGs, or the 
involvement of constrictory PGs in NEPI constriction (Luscher et al, 1990). However, in the 
Luscher et al (1990) study, PRO was not administered along with NEPI, and the rats were 
significantly older, suggesting that differences in the responses may be due to an increased 
release of constrictory PGs in the older rats, possibly modulating the dilatory effects of NEPI, 
although no known study has addressed this hypothesis.   
 Co-incubation with LN and INDO in the KCl dose-response curve increased AUC by 
67% in SHR and by 30% in WKY over respective CON groups, while the NEPI responses to 
LN INDO were similar between strains (Figures 9 and 11). In the KCl response, there was 
also a trend towards an improvement in AUC in LN INDO over INDO alone (p=0.063), 
suggesting that the additional treatment with LN improved AUC over INDO alone. In support 
of the present study, LN has been previous shown to improve the response to KCl, where two 
NOS inhibitors (LN and N
G
-nitro-L-arginine) increased the KCl response in both WKY and 
SHR perfused mesenteric beds while two COX inhibitors (INDO and mefenamic acid) did not 
alter KCl response in SHR (Le Marquer-Domagala and Finet, 1997). However, in the present 
study, LN INDO did not alter 1-AR-mediated constriction, a result that has been previously 
shown in 12wk old WKY where the NEPI dose response curve was not altered by LN or LN 
INDO (Lang et al, 1995). Conversely, in SHR, Lang et al (1995) demonstrated a 23% greater 
NEPI AUC with LN over CON, while LN INDO showed no difference, suggesting that NEPI 
releases dilatory NO which is somehow reversed by COX inhibition. In the present study, 
INDO did not alter NEPI responses, so the lack of change with LN INDO co-incubation is not 
likely due to a reversal of the effects of LN with additional INDO. Taking the constriction 
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responses together, the results of the present study suggest that, in both SHR and WKY, KCl 
but not NEPI, stimulates the release of NO, whereas PGs are not released by either KCl or 
NEPI.  
  
MODULATION OF ENDOGENOUS H2O2 BY TEMPOL 
 An additional component of the present study addressed the effect of supplementation 
with the antioxidant TEMPOL on the level of endogenous H2O2 available for endothelium-
dependent dilation. As a membrane-permeable SOD mimetic, TEMPOL could convert O2
-
 to 
H2O2, thereby releasing H2O2 for dilation. Pilot work demonstrated that TEMPOL 
administration to SHR or WKY preconstricted mesenteric vessels caused a 32-52% dilation 
over 20-30min that was partially reversed by the subsequent addition of CAT over 10-20min, 
an effect that was no different between SHR and WKY (Figure 19). This H2O2-dependent 
effect of TEMPOL is supported by evidence from SD mesenteric arteries where 
preconstricted vessels had a transient dilation to 1mmol/L TEMPOL that was reversed by 
CAT (Chen et al, 2007). This data, taken in isolation, could seemingly illustrate the separate 
effects of TEMPOL and CAT on 1-AR-mediated tone, rather than the action of CAT to 
reverse the H2O2 provided by TEMPOL. However, in the present study, CAT pre-incubation 
causes a reduction, rather than an increase, in NEPI preconstriction prior to the ACh curve, 
suggesting that CAT alone does not potentiate 1-AR-mediated constriction. Furthermore, the 
TEMPOL alone or TEMPOL LN INDO treatments tended to increase H2O2 accumulation in 
the Amplex Red assay by 24-60% isolated mesenteric arteries of both strains over PSS (SHR 
ACh TEMPOL p=0.085, SHR ACh TEMPOL LN INDO p=0.064, WKY TEMPOL p=0.063), 
an effect that was inhibited by the addition of CAT, and supported by similar experiments in 
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SD mesenteric arteries (Chen et al, 2007). Thus, direct administration of TEMPOL caused 
dilation in SHR and WKY vessels that was partially reversed with CAT, suggesting that 
TEMPOL released H2O2 for dilation. 
In the mesenteric arteries of SHR and WKY, TEMPOL alone did not alter responses 
to ACh, SNP, NEPI, or KCl, from CON suggesting that changes in O2
-
 or H2O2 were not 
enough to alter vasomotor tone following stimulation by an agonist. In addition, co-incubation 
with TEMPOL LN INDO did not alter ACh or SNP responses from LN INDO, suggesting 
that even in the absence of NO and PGs, TEMPOL did not release adequate H2O2 to affect 
dilation. However, in SHR but not WKY, the co-administration of TEMPOL CAT LN INDO 
prevented the decrease in ACh dilation occurring with CAT LN INDO compared to LN 
INDO (Figure 4), and in the SNP dose response curve, TEMPOL CAT LN INDO incubation 
reduced AUC by 7-8% below CAT LN INDO (Figure 7). When the SNP and ACh results are 
taken together, TEMPOL may maintain endothelium-dependent dilation in SHR by 
scavenging O2
-
, rather than through the provision of H2O2, an effect made even more 
important by a decreased dilatory response of the VSM with the TEMPOL CAT LN INDO 
treatment. Previous studies contrast with the present findings and support the release of H2O2 
by SOD mimetics to stimulate vasodilation (Morikawa et al, 2003; Matoba et al, 2003). 
However, PEG-SOD has also been shown not to improve the 3NP component of ACh-
induced dilation in porcine coronary arteries (Matoba et al, 2003), and to have no effect on 
the 3NP-mediated component of ACh-induced dilation in mouse mesenteric arteries (Ellis et 
al, 2003), although this latter study also failed to demonstrate a role for H2O2 as an 
endogenous vasodilator in the absence of PEG-SOD. In additional support for role of 
TEMPOL as an O2
- 




measured by lucigenin chemiluminescence in renal cortical microsomes (Fulton et al, 1997). 
Similarly, through some undefined mechanism, increased O2
-
 buffering by TEMPOL in SHR 
may improve the function of calcium-activated K
+
-channels or myoendothelial gap junctions, 
both factors implicated in 3NP mediated dilation (Feletou and Vanhoutte, 2006; Griffith et al, 
2005), reinforcing the present findings where that TEMPOL may have preserved ACh-
induced dilation in SHR through scavenging O2
-
 rather than by providing H2O2, but only in 
the presence of LN and INDO. 
In the present study, incubation in TEMPOL CAT LN INDO increased maximal NEPI 
constriction by 25-30%, increased AUC by 28-31%, and increased NEPI preconstriction for 
the ACh curve by 33-63% compared to CAT LN INDO, effects that were consistent across 
strains. Together, these NEPI data imply a possible impairment of the 1-AR-mediated 
response by O2
-
. It is unlikely that the improvement in NEPI response could have been 
mediated by impairment of the endothelium dependent dilatory pathways as the ACh response 
parameters were either improved or unchanged by TEMPOL CAT LN INDO when compared 
to CAT LN INDO. Similarly, the endothelium-independent response to SNP was slightly but 
significantly impaired by TEMPOL when combined with CAT LN INDO, but not impaired 
enough to explain the improvement in the NEPI response. In mesenteric arteries, endogenous 
OH
-
 inhibits 1-AR mediated constriction (Girouard and Champlain, 2005), and may lend 
support to the present finding as O2
-
 can quickly dismutate into OH
-
 in the presence of iron or 
copper through the Haber-Weiss reaction (Feletou and Vanhoutte, 2006). The results of the 
present study, combined with other findings, suggest that TEMPOL may scavenge the O2
-
 that 
is being converted to OH
-




BODY WEIGHT AND HEMODYNAMICS 
As expected, SHR rats had an elevated blood pressure compared to WKY. SHR also 
had an increased left kidney-to-body weight ratio; however, this parameter was not correlated 
to endothelial function or the hemodynamic measures, suggesting that the kidney weight was 
not related to the degree of hypertension. The heart mass was increased in SHR in the present 
study, which is supported by previous work where, LV and HM were increased in the SHR 
when expressed in absolute mass or relative to body mass, indicating that hypertrophy of heart 
has occurred (Graham and Rush, 2004; Quadrilatero and Rush, 2006). However, the increased 
heart mass in the present study was not conserved when expressed relative to body weight, 
which suggests that, although the heart is larger in the SHR, it was related to the greater body 
weight of this strain, and not due to the establishment of LV hypertrophy.  
 
LIMITATIONS. 
 The present study was limited by methodological and technical considerations. Firstly, 
the 860U/mL CAT purified from bovine liver used in the study was at a lower dose than other 
studies where the role of exogenous H2O2 was confirmed (1000-6250U/mL: Miura et al, 
2003; Morikawa et al, 2003; Matoba et al, 2000, 2003) or refuted (2500U/mL: Ellis et al, 
2003). However, the present study did demonstrate the expected effect of CAT by 1) an 
impairment of 3NP-mediated dilation with CAT LN INDO, 2) a rightward shift in the SD 
H2O2 dilatory curves following 860U/mL CAT pre-incubation, and 3) a complete reduction in 
the Amplex Red measures of H2O2 accumulation. These findings suggest that the 860U/mL 
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dose of CAT was adequate to scavenge H2O2 in multiple experiments, thereby allowing an 
investigation of the role of endogenous H2O2 in 3NP dilation.  
 The present study used cell-impermeable CAT and cell-permeable TEMPOL; thus, the 
effects of TEMPOL as an O2
-
 scavenger or a H2O2 producer, and the implications on 
vasomotor function, may have been obscured. Exogenous H2O2 is known to cross cell 
membranes freely, creating a 7-fold concentration gradient between extracellular and 
intracellular spaces (Antunes and Cadenas, 2000), and suggests that the endogenously 
produced H2O2 could diffuse to the extracellular space to be scavenged by the extracellular 
CAT. As such, CAT would act as an extracellular “sink” for exogenous H2O2 by causing a 
concentration gradient that favoured diffusion of H2O2 to the extracellular space. However, 
the H2O2 produced by TEMPOL may have had an intracellular effect before being scavenged 
by extracellular CAT, thereby underestimating the effects of TEMPOL as a H2O2 producer 
and overemphasizing the O2
-
 scavenging properties. Through a similar mechanism, the 
extracellular Amplex Red reagent may have undestimated the H2O2 produced by TEMPOL. 
The effectiveness of 6250U/mL CAT on the reversal of TEMPOL-induced H2O2 production 
has been shown in the mesenteric arteries of SOD-1
-/-
 mice (Morikawa et al, 2003); however, 
it is uncertain whether the H2O2 accumulation from TEMPOL was completely scavenged by 
the 860U/mL CAT used in the present study. 
 The NO donor SNP assessed the sensitivity of the VSM for NO, and changes in 
endothelium-independent dilation with the various drug treatments. However, it was not 
possible to assess differences in the sensitivity of the VSM for PGs or 3NP-mediated dilators 
using SNP, as these pathways were not directly stimulated. Previous work suggests that 
endogenous H2O2 may operate through a PKC/sGC/cGMP mechanism activated by SNP (Itoh 
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et al, 2003; Leung et al, 2006), although no differences in the SNP responses were observed 
between strains in the current study. The use of SNP alone, and not VSM hyperpolarizing 
drugs, limited the ability of the present study to uncover the mechanisms at the VSM 
activated in response to endogenous H2O2.  
 
CONCLUSION. 
 This study demonstrated the involvement of endogenous H2O2 in endothelium-
dependent dilation of rat mesenteric arteries when NO and PG were inhibited. The role of 
endogenous H2O2 was also exaggerated in the SHR rat resistance arteries, suggesting that this 
pathway may contribute to the maintenance of some, albeit limited, endothelial vasomotor 
function in SHR. Exogenous H2O2 was able to dilate mesenteric arteries and CAT reduced 
H2O2 accumulation from isolated mesenteric vessels, supporting the role for H2O2 in the 
vasomotor function of SHR and WKY. This study also provided evidence for a potential role 
for COX-1 inhibition in the provision of H2O2 for dilation in SHR mesenteric arteries, 
demonstrated by the improvement of endothelium-dependent dilation with INDO, the 
relationship between COX inhibition and the CAT effect, and the upregulation of COX-1 
expression in the SHR mesenteric arteries. This is the first study to demonstrate the role of 
endogenous H2O2 in rat resistance vessels, its elevated contribution to dilation in SHR, and a 
potential role for COX inhibition on the provision of endogenous H2O2 for dilation.  
 The present study also demonstrated an increased reliance on NO for dilation in SHR 
compared to WKY, which may have been related to increased activation of eNOS in 
mesenteric arteries. In addition, the 3NP component of dilation was larger in the mesenteric 
arteries of WKY compared to SHR, suggesting that reduced 3NP may be involved in impaired 
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vasomotor function in hypertension, and that factors other than NO, PGs, or endogenous H2O2 
likely contribute to vasomotor function in resistance arteries. Finally, TEMPOL, in the 
presence of CAT LN INDO provided improvement in the responses to 1-AR-mediated 
constriction, suggesting that O2
-
 may impair constriction in this preparation. 
 
FUTURE DIRECTIONS. 
 Future studies will aim to define the role of COX-1 in the bioavailability of 
endogenous H2O2, and the particular mechanism involved in dilation of the VSM by 
endogenous H2O2. Firstly, COX-1 and COX-2 specific inhibitors would confirm the primary 
involvement of COX-1 in the function of hypertensive mesenteric arteries, and the co-
incubation of LN with CAT could confirm the inhibition of COX-1 and the availability of 
H2O2 for dilation when compared to the other drug treatments. Furthermore, simultaneous 
measures of ROS and vasomotor function, using confocal microscopy, could verify the 
accumulation of H2O2 in the various drug treatments and the possibility of cellular 
compartmentalization. In addition, the use of hyperpolarizing factors and exogenous PGs 
could clarify the VSM pathway involved in the H2O2 response, and the influence of 
hypertension on this pathway. Further studies could also assess the responses of resistance 
vessels following AII-induced hypertension, or long term treatment with COX-1 inhibitors to 
maximize endogenous H2O2 and to investigate the tipping point between vasoactive mediation 







APPENDIX A- SUPPLEMENTARY METHODS 
KCl CURVE SOLUTIONS 
To achieve the required dose of KCl, a volume of stock oxygenated 37C PSS was created in 
the absence of NaCl or KCl (NaK-free-PSS concentration (mmol/L): 1.17MgSO4 7H2O, 
1.18KH2PO4, 2.50CaCl2 2H2O, 25.00NaHCO3, 0.03EDTA, 5.50 D-Glucose). For a given 
dose of KCl, 10mL of NaK-free-PSS was aliquoted and a volume of NaK-free-PSS was 
replaced with the required volume of stock NaCl (4.123mol/L dissolved in NaK-free-PSS) 
and KCl (3.3mol/L dissolved in NaK-free-PSS) (Appendix A, Table) and the appropriate in 
bath concentration of inhibitors. 
Table: KCl and NaCl Volumes for KCl Dose-Response Curve 
[KCl] in bath  
(mmol/L) 
Volume of stock 
KCl/10mL bath (μL) 
[NaCl] in bath (mmol/L) 
Volume of stock 
NaCl/10mL bath (μL) 
0 0 124 300 
10 30 114 276 
20 60 104 252 
30 90 94 227 
40 120 84 203 
50 150 74 179 
60 180 64 155 
70 210 54 130 
80 240 44 106 
90 270 34 82 






WESTERN BLOTTING SOLUTIONS. 





Concentration Compound Company 
1.46M Sucrose Sigma-Aldrich 
7.5% wt/vol SDS Bioshop 
62.5mM Tris-HCl Sigma-Aldrich 
2mM EDTA Sigma-Aldrich 
0.2M DTT Bioshop 
0.01% wt/vol Bromophenol Blue Sigma-Aldrich 
 
TRANSFER BUFFER 
Concentration Compound Company 
25mM Tris Base Bioshop 
0.2M Glycine Sigma-Aldrich 
20% vol/vol Methanol Sigma-Aldrich 













APPENDIX B – SUPPLEMENTARY RESULTS 
 
 
ACUTE TREATMENT WITH ANTIOXIDANTS. 
 The direct effects of TEMPOL as a potential H2O2 producer, and its possible reversal 
by CAT, were tested in both SHR (n=7) and WKY (n=5) following a NEPI preconstriction  
(Figure 20). The preconstrictions were no different between strains (plateau preconstriction; 
SHR: 15.6±1.2 vs WKY: 15.3±1.2nM, p=0.829). Similarly, the dilation with 1mM TEMPOL, 
which occurred over 20-30min, was no different between strains (SHR: 8.1±1.2 vs WKY: 
5.0±1.8nM, p=0.196). In addition, the reconstriction with the subsequent addition of 
860U/mL CAT, which also occurred over 20-30min, was no different between strains (SHR: 
2.1±1.0 vs WKY: 1.4±0.7, p=0.261). Importantly, CAT did cause a reversal of a component 
of the TEMPOL effects, irrespective of strain (p=0.014). When data was expressed relative to 
preconstriction, there are no differences in the trends mentioned above.  
 
 
VASOMOTOR RESPONSES IN ENDOTHELIUM-DENUDED ARTERIES 
 I) Rat and Ring Baseline Parameters 
 A series of experiments were completed on endothelium intact (E+) and endothelium-
denuded (E-) SD mesenteric vessels to assess the effectiveness of the denuding procedure 
prior to assessing the role of the endothelium in the vasomotor responses to exogenous H2O2. 
No differences were found in the normalized diameter of E+ and E- vessels (E+: 
180.3±12.4μm (n=29) vs E-: 208.5±11.5μm (n=24); p=0.079). To ensure the removal of the 
endothelium, an endothelium function tests was completed on both E+ and E- vessels (n=23-
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24), which developed the same tension to NEPI preconstriction (E+: 9.7±1.2mN vs E-: 
10.2±1.1mN; p=0.677), but the dilation to 10
-6
mol/L ACh was greatly impaired in E- (E+: 
35.4±3.9% vs E-: 5.9±1.0%; p<0.001). 
 
II) Vascular Responses in E+ and E- Vessels 
In the ACh dose-response curve, E- vessels (n=9) only dilate to ~25% of the E+ vessel 
(n=10) maximum (E+: 61.0±7.1% (n=10) vs E-: 15.4±1.9% (n=9); p<0.001) and AUC was 
reduced by ~81% in E- compared to E+ (E+: 173.9±20 vs E-: 32.5±3.5; p<0.001). Similarly, 
the sensitivity of the E- vessels was reduced compared to E+ (E+: -8.9±0.2 vs E-: -8.1±0.3;, 
p=0.025). In the SNP dose responses curve, E- have an increased AUC compared to E+ (E+: 
273.0±30.4 (n=5) vs E-: 353.4±17.0 (n=5); p=0.050); however, maximal relaxation response 
and logEC50 remained unchanged (E+: 75.8±5.9% vs E-: 86.9±1.5% p=0.104; E+: -7.6±0.2 vs 
E-: -8.1±0.2; p=0.081). Finally, in the NEPI dose-response curve, E- vessels maximally 
constrict ~2-fold more than E+ (E+: 5.96±0.69mN (n=9) vs E-: 11.69±1.75mN (n=11); 
p=0.012) with a ~2-fold greater AUC in E- (E+: 18.9±2.0 vs E-: 37.1±5.6; p=0.011) and an 
unchanged logEC50 (E+: -7.2±0.1 vs E-: -7.2±0.1; p=0.872). 
 
III) Responses of E+ and E- vessels to exogenous H2O2 and CAT pre-incubation 
 For the H2O2 dilatory curves, E+ and E- vessels were administered H2O2 following a 
preconstriction (n=3-5) (Table 8, Figure 21). Additional experiments involved pre-incubation 
of E+ and E- with 860U/mL CAT prior to the H2O2 dilation curve (n=2/group).  The NEPI 
preconstrictions were no different between denuding conditions or the presence of CAT (2-
way ANOVA: Main effect of denuding: p=0.196, main effect of CAT pre-incubation, 
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p=0.229, interaction effect denuding*pre-incubation: p=0.826). Due to the non-sigmoidal 
profile of the CAT pre-incubation curves, the AUC was the best measure of differences with 
endothelium and with the treatment (2-way ANOVA: Main effect of denuding: p=0.019, main 
effect of CAT pre-incubation, p=0.003, interaction effect denuding*pre-incubation: p=0.652). 
Thus, denuded vessels demonstrated a reduced total response to H2O2 when compared to 
intact vessels collapsed, across both drug condition (E+CON: 264.0±35.2 E+CAT: 
119.1±23.3 vs E- CON: 157.9±1.6 E-CAT: 41.5±9.5). In addition, pre-incubation with 
860U/mL CAT greatly reduced the AUC in both E+ and E- groups by ~55-74%. When 
assessing the H2O2 dilatory responses in E+ and E- vessels in the CON condition alone, no 
difference was observed between maximal dilation (E+ CON: 89.4±5.9% vs E-CON: 
82.6±3.5%; p=0.413) or logEC50 (E+ CON: -4.9±0.6 vs E- CON: -3.7±0.0; p=0.190); 
however, there was a trend towards a ~40% decrease in AUC in E- vessels (E+ CON: 
264.0±35.2 vs E- CON: 157.9±1.6; p=0.052). Importantly, both E+ and E- vessels constrict to 
H2O2 to the same extent at 10
-2
mol/L H2O2 achieving a maximum of 2-3mN (n=2/group) 
(Figure 21). 
Table 8: Endothelium-Dependent Dilation of SD Intact and Denuded Arteries 
ACh P values 
 Strain Drug Strain*Drug 
MR (%) <0.001 0.002 0.013 
logEC50 (mol/L) 0.291 0.029 0.004 
AUC (AU) <0.001 0.002 0.003 
p-values from ANOVA. ACh, acetylcholine; MR, maximal relaxation; AUC, area under the 
dose-response curve. Endothelium, main effect of denuding; Drug, main effect of CAT pre-





































Figure 19. Representative tracing of TEMPOL and CAT experiment. A, Preconstriction with 
10
-5
mol/L NEPI with PRO present; B, Injection of 10mmol/L TEMPOL; C, Addition of 



































Figure 20. H2O2-induced dilation and constriction. Values are mean±s.e.m., n per group in 
parenthesis. NEPI, norepinephrine; Dilation, relaxation from NEPI preconstriction; 
Constriction, relative developed tension from quiescent vessel expressed relative to NEPI 
preconstriction in endothelial function test. Symbols for statistical difference were omitted for 





Figure 21. H2O2-induced dilation and constriction in SD rats. Values are means±s.e.m., n per 
group in parenthesis. Top: H2O2-induced dilation. Bottom: H2O2-induced constriction. E+, 
endothelium-intact; E-, endothelium-denuded; NEPI, norepinephrine; CON, untreated; CAT, 
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